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COLLECTING LYMPHATIC VESSEL PERMEABILITY TO ALBUMIN AND ITS 
MODIFICATION BY NATRIURETIC PEPTIDES 
 
Joshua Paul Scallan 
Dr. Virginia Huxley, Dissertation Supervisor 
 
ABSTRACT 
 
Macromolecules and water leave the blood microcirculation and bathe the tissues 
of the body, and cannot be constitutively reabsorbed by the blood vessels, necessitating 
an outflow pathway that is comprised by the lymphatic vasculature. The mechanisms 
underlying the transport of macromolecules and water to or from the lymphatic vessels 
have not been elucidated fully until now, due to the difficulty in manipulating these 
structures. Here we demonstrated that the microfluorometric technique designed to assess 
blood capillary solute permeability (Ps) could be modified to determine the Ps of single 
collecting lymphatic vessels. Lymphatic endothelium has recently been shown to be 
derived from the cardinal vein, suggesting that these endothelial types share many genes, 
thus functions; we hypothesized that collecting lymphatic and venular Ps, as well as its 
response to natriuretic peptides, do not differ. In accordance, we demonstrated that the 
median lymphatic and venular Ps to albumin did not differ, nor did their diffusive 
permeabilities (Pd) or estimated hydraulic conductivities (Lp). Follow-up studies were 
then performed to determine whether protein was absorbed or expelled by collecting 
lymphatics, and revealed that collecting lymphatic vessels possessed concentration 
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gradients of total protein and albumin favoring their loss into the tissue, contrary to our 
expectations.  
During perfusion with atrial or brain natriuretic peptides (ANP and BNP; 
hormones released during fluid shifts such as congestive heart failure), the Ps responses to 
both peptides mirrored that of the venules. However, a differential sensitivity to these two 
peptides existed such that collecting lymphatics possessed greater Ps responses to BNP 
(2.7-fold) than ANP (2.0-fold). Further, lymphatic contraction amplitude and frequency 
could be monitored while these peptides were infused; ANP abolished contractions in a 
nitric oxide-dependent manner, while BNP increased contraction amplitude and 
frequency by ~2-fold.  
In summary, the data presented in this dissertation show that collecting lymphatic 
vessels are permeable to albumin, protein diffuses into the tissue under basal conditions, 
and natriuretic peptides double this permeability. From these data we conclude that the 
lymphatic vasculature likely plays a prominent, previously unrecognized role in tissue 
exchange with several of the implications examined in this dissertation.   
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CHAPTER 1: INTRODUCTION 
 
Microvessels carrying whole blood transport sugars, proteins, lipids and gases to 
and from the tissues to support life on a cellular and organismal level. To allow this 
exchange, vessels must be porous – or permeable – to both solute and water. As we will 
discuss, microvessels of most organs are unable to sustain reabsorption of their 
extravasated water and macromolecules from the tissues, necessitating an outflow 
pathway to prevent edema formation, a state ultimately incompatible with life. The 
lymphatic vasculature alone comprises the pathway required to maintain the steady return 
of this capillary filtrate to the blood circulatory system. Consequently, the lymphatic 
vasculature is associated intimately with the control of fluid and macromolecule 
movement as well as establishment of their homeostasis.  
Until now the mechanisms governing solute and water transport across the walls 
of lymphatic vessels remained undefined despite acknowledgment of their importance to 
the understanding fluid homeostasis and edema formation. Therefore, the goal of this 
thesis was to develop a method to measure the permeability of the lymphatic vasculature 
to solutes, to put those measures into a meaningful context, and to determine definitively 
whether lymphatic vessel permeability is static or dynamic – i.e., whether permeability is 
a constant, or is regulated during conditions encountered in health and/or disease. 
Consequences of lymphatic vessel permeability will be discussed in terms of the ease 
with which solute (permeability, Ps) and water (hydraulic conductivity, Lp) traverse the 
lymphatic endothelial barrier.  
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Unfortunately for the lymphatic circulatory system, there exists a dearth of 
knowledge giving rise to many assumptions. A relevant summary of lymphatic vessel 
function, as well as the introduction of a consistent nomenclature for the elements of the 
lymphatic vasculature, is required before proceeding.  
 
Lymphatic Anatomy and Nomenclature 
 
While study of the blood vascular system dates back to the sixth century BC, the 
lymphatic vasculature was not “discovered” until 1622 by Asellius (6). In stark contrast 
to the blood vasculature, the lymphatic circulatory system has been far less extensively 
studied. The reason for this is not its late discovery, per se, but rather pertains to the 
prevailing misperception that the lymphatics represent a largely passive system for return 
of extravasated fluid and proteins to the systemic circulation, to the difficulty of 
visualizing lymphatic vessels in the tissue, and to the lack of specific molecular markers 
to distinguish cells from this circulatory system from that of the blood vasculature until 
recently (26). As such, no common nomenclature for the lymphatic vasculature has been 
agreed upon, so one previously used for rat mesenteric lymphatics will be introduced 
(110).  
Interstitial fluid, formed from solute and fluid extravasated from the capillaries, 
enters blind-ended sacs composed only of an endothelial layer tethered to the interstitial 
matrix. These bulbous sacs (10-60 µm diameter) are called initial, or terminal, 
lymphatics. Initial lymphatics possess overlapping endothelial cells that behave 
collectively like a valve, only permitting entry of fluid, solute, and cells into the lumen of 
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these vessels. The fluid, thereafter referred to as lymph, next moves into lymphatic 
vessels of a similar diameter, termed microlymphatics here. Microlymphatics consist of 
an endothelial layer and basement membrane (126). Since the phrase ‘lymphatic 
capillary’ is sometimes applied to initial and microlymphatics collectively, and 
‘lymphatic capillaries’ may be much larger than traditional capillaries carrying whole 
blood, this ambiguous phrase will be avoided hereafter. Microlymphatic vessels then 
carry lymph towards the larger collecting lymphatic vessels. Collecting lymphatics (50-
200 µm diam.) are composed of endothelial cells, a basement membrane, lymphatic 
muscle cells, pericytes, and endothelial valves that prevent retrograde lymph flow (96, 
133). Pericytes do not envelope the smaller initial and microlymphatics (96). Valves are 
present in collecting lymphatics and differ from the initial lymphatic ‘valve’ in that they 
consist of two modified endothelial cell leaflets that meet in the vessel lumen, not unlike 
valves of the larger mammalian veins. The lymphatic muscle layer is unique in that it 
possesses both tonic and phasic contractile activity (113, 133). Phasic contractions, 
referred to as spontaneous contractions, aid in propelling lymph along the intervalvular 
segments of the lymphatic vessel, called lymphangions. After passing through lymph 
nodes and then larger collecting lymphatic ducts, lymph is finally propelled to the 
thoracic duct, which empties into the left subclavian vein (see Figure 1).  
The anatomy of collecting lymphatic vessels appears similar to that of comparable 
veins in that they both are low-pressure vessels vested with a muscle layer and 
intraluminal valves. In support of the theory of lymphatic development originally 
proposed by Sabin (106), one group has shown that lymphatic endothelial cells are 
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derived directly from the cardinal vein (114). Akin to the venules numerous cytoplasmic 
vesicles have been reported in initial lymphatic endothelium (1, 21, 69-71, 88). To date, a 
role for these vesicles in solute uptake has not been elucidated fully. Further, whether 
lymphatic vessels possess other features similar to the vessels carrying whole blood – 
such as a glycocalyx or caveoli – has not been demonstrated. Nor is it known whether 
lymphatic vessels possess the same receptors to physiological agonists and antagonists as 
displayed by the blood vasculature.  
Although the preceding description is accurate for the rat mesenteric lymphatic 
vasculature, it is important to recognize that lymphatic vessel morphology varies greatly 
between organs. Since it is beyond the scope of this dissertation to thoroughly summarize 
these varying anatomical features, the reader is directed to several excellent detailed 
reviews for this information (8, 91, 113). Two of these reviews (8, 113) summarize 
classical views on several aspects of the lymphatic vasculature: the present chapter will 
provide the reader with the relevant, current perspectives on lymphatic vessel function.  
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Lymph Formation 
Lymph formation refers to the entry of fluid and protein into the initial lymphatics 
from the surrounding tissue. The mechanisms responsible for this process are poorly 
understood, but two main hypotheses have been proposed. The first is that an osmotic 
gradient becomes established across the initial lymphatic wall through sieving of protein 
that then generates its own convective flow by pulling in protein-containing interstitial 
fluid against a concentration gradient (20). Very little, if any, experimental support exists 
for this theory, which is in direct violation of the second law of thermodynamics, despite 
its original appearance nearly four decades ago. Therefore, the following discussion will 
focus on the second hypothesis, that a hydrostatic pressure gradient is needed to fill the 
initial lymphatics.  
As stated before, the initial lymphatics possess overlapping endothelial cells 
tethered to the tissue. Thus, when the tissue becomes hydrated it swells and pulls apart 
the endothelial cells to form ~2 µm diameter pores that act like a nonselective one-way 
valve, trapping fluid, solute, and cells passively (124). Considering their unique structure, 
one would arrive at the logical conclusion that a pressure gradient across the interstitium 
drives fluid and solute accumulation within the initial lymphatics. From the few studies 
of interstitial pressure gradients it was shown that a gradient of 0.2 to 0.8 cmH2O exists 
(48, 136). At first glance this pressure gradient seems small, but others have calculated 
that a pressure head of only 0.12 cmH2O is adequate to drive the capillary filtrate into the 
low resistance initial lymphatics (113). One foreseeable problem with this hypothesis is 
that the interstitial pressures measured routinely are negative values relative to 
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atmospheric, which would cause water to flow out of any vessel into the interstitium (24, 
44). Significant overlap of interstitial and initial lymphatic pressures measured 
simultaneously was observed (24), depending on the superfusion solution and the time of 
measurement (immediately following exteriorization or 30 minutes later). Particularly 
interesting was that 30 minutes after exposure of the mesentery, superfused with oil to 
preserve natural tissue hydration, respective pressures in the interstitium and initial 
lymphatics were -0.2 and -0.25 mmHg. Therefore, it is possible that a positive pressure 
gradient can allow fluid to enter the initial lymphatics even in the face of a negative 
interstitial pressure. More current support for this hypothesis has been reported (85).  
A passive interstitial pressure gradient, while sufficient, does not provide a 
complete description of every mechanism contributing to the formation of lymph. 
Pulsation of arteries was shown to aid in removal of interstitial tracer, which ceased after 
application of a steady arterial pressure (92). Likewise, in the bat wing preparation, 
cyclical dilatation of the venules provides a form of extrinsic pumping that also 
stimulates intrinsic spontaneous contractions of collecting lymphatics (35). Other factors 
that increase local tissue pressure and facilitate lymph formation include respiration, 
muscle contraction (e.g., peristalsis, walking), elevation of capillary filtration (e.g., 
venous hypertension, increased capillary permeability), and massage. Opposite to an 
increase in interstitial pressure, a variant of the hydrostatic pressure hypothesis posits that 
spontaneously contractile collecting lymphatic lymphangions, during their relaxation 
phase, are able to generate a suction that draws interstitial fluid into the initial lymphatics 
(99). Negative pressures produced by isolated bovine mesenteric collecting lymphatics 
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under “low filling” states have been reported (37), but direct evidence for transmission of 
this suction to the initial lymphatics is needed.  
Further support for the hydrostatic pressure gradient hypothesis is derived from 
studies demonstrating a positive correlation between interstitial pressure and lymph flow, 
which are discussed next. 
 
Interstitial Fluid Pressure and Its Influence on Lymph Flow 
A convincing argument for an interstitial pressure gradient to drive lymph 
formation has been outlined in the previous section. The potential of the initial lymphatic 
lumen to collapse under a positive pressure difference is minimized by their unique 
anatomy. Initial lymphatic endothelial cells are tethered to the interstitium by anchoring 
filaments (68) responsible for holding the lumen open during conditions of increased 
tissue pressure or swelling, creating large (~ 2 µm diameter) interendothelial pores. The 
pores are a consequence of the “button”-like pattern of endothelial junctional adhesion 
proteins, in contrast to the contiguous expression of these molecules in blood vessel and 
collecting lymphatic endothelium (9). Thus, interstitial fluid is able to access the initial 
lymphatic lumen especially during edematous states when tissue pressure becomes 
positive.  
Possibly as a result of the direct communication of the interstitial fluid and the 
lumen of the initial lymphatics, interstitial pressure and lymph flow are positively related. 
Several studies where tissue pressure was measured using the capsule technique provide 
direct evidence for this relationship (40, 121). Figure 2A, from Taylor et al. (122), shows 
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that the rise of lymph flow in the dog hind leg is steepest at tissue pressures of ~ 0-1 
cmH2O and attains a sustained maximal value when tissue pressure reaches 2 cmH2O. 
The importance of this curve is that it maintains a constant interstitial volume due to the 
tight correlation between interstitial volume and interstitial pressure shown in Figure 2B 
(42). Two mechanisms protecting against edema (i.e., edema safety factors) are evident 
from Figure 1, assuming that interstitial pressure is normally negative: 1) Since 
interstitial pressure must rise above 2 cmH2O for lymph flow to plateau, large changes in 
interstitial pressure can be accommodated before edema develops, and 2) an elevated 
lymph flow will return quickly the interstitial volume back to normal levels, as long as 
the excess volume does not exceed the capacity of the lymphatic circulation. Thus a small 
increase in interstitial volume greatly increases its pressure, promoting lymph flow that 
acts to restore the interstitial volume to normal.  
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Propulsion of Lymph by the Lymphatic Muscle Pump 
The field of research examining the functional and molecular control of lymphatic 
contractility has been productive in the past two decades. One key discovery is that 
lymphatic muscle may act as a functional hybrid between smooth and cardiac muscle 
because it contains molecular machinery from both cell types (84). This has stimulated 
new hypotheses about how collecting lymphatics are able to independently regulate both 
tonic and phasic contractions.  
Hydrostatic pressure increases progressively as lymph moves downstream into 
larger vessels of the lymphatic vasculature. In contrast, peripheral veins in the human 
experience a greater hydrostatic pressure than the downstream central veins, especially 
when standing, owing to the effects of gravity. Restated, the pressure gradient produced 
by the heart, in addition to the extrinsic venous pump, provides the driving force for 
venous return (8). The lymphatic vasculature has no such pressure head (i.e., vis a tergo) 
so lymph does not – and cannot – drain passively through the lymphatic vessels, but 
requires propulsion. However, under edematous conditions, the interstitial pressure rises 
so that lymph may flow down a pressure gradient.  
Lymph is transported throughout the lymphatic vasculature by intrinsic phasic 
contractions generated by the lymphatic muscle of collecting lymphatics that, along with 
valves, are necessary for unidirectional lymph flow. The spontaneous contractions are 
analogous to the cardiac contraction cycle consisting of a contraction and relaxation 
phase, stroke volume, and ejection fraction (12). For comparison, the measured ejection 
fraction and frequency of rat mesenteric collecting lymphatics were ~67% and 6 min-1, 
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respectively (12). Understanding the functional and molecular regulation of lymphatic 
spontaneous contractions is essential for developing therapeutic treatments for edema 
(and lymphedema) centered on augmenting contraction amplitude and/or frequency.  
Since the walls of collecting lymphatics are vested with muscle cells, they are 
able to regulate their diameter and tone, therefore modulating lymph flow resistance. 
Several factors, both mechanical and chemical, are able to regulate collecting lymphatic 
tone (133). Mechanical stimuli include lymph flow, shear stress, hydrostatic pressure, and 
temperature. Hydrostatic pressure has been shown to elicit a myogenic response in 
collecting lymphatic muscle (measured during the relaxation phase) analogous to the 
arteriolar myogenic response (32). In that study an elevation in hydrostatic pressure 
induced constriction, thus reducing the end diastolic diameter of isolated collecting 
lymphatics, similar to the arteriolar myogenic response to pressure. Chemical factors 
influencing collecting lymphatic tone include neurotransmitters, neuropeptides, 
hormones, and metabolites. For instance, addition of the neuropeptide substance P to the 
superfusion bath potentiates the effect of pressure on myogenic tone and increases basal 
collecting lymphatic tone (4, 31).  
Similar to cardiac myocytes, length-tension curves have been determined for the 
perivascular muscle of collecting lymphatics, arterioles, and venules (142). Wall tension 
and stress derived from these curves were found to be lowest in rat mesenteric 
lymphatics, while mesenteric veins possessed higher tension and stress, and that of 
mesenteric arteries was the highest. Functionally, this makes sense in that arterioles, the 
resistance vessels, constrict to regulate pressure and flow; venules and lymphatics possess 
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lower hydrostatic pressures reflecting their roles as capacitance vessels. The same group 
estimated the optimal preload (or hydrostatic pressure) for collecting lymphatic tone 
during peak active force to be ~ 5-13 cmH2O, which compares well with measures of in 
vivo hydrostatic pressure (110, 143).  
Other research has focused on the regulation of collecting lymphatic phasic 
activity. Functional studies demonstrated that lymph flow inhibits spontaneous 
contraction frequency and amplitude of both collecting lymphatic and thoracic duct 
isolated vessels (38). However, the conclusion was that in vivo total lymph flow (defined 
as passive flow plus contraction-generated flow) would not be diminished as expected. 
Instead, a reduction of pumping activity was suggested as a mechanism to reduce the 
outflow resistance in the presence of high passive flows.  
Another vessel possessing spontaneous contractile activity besides the collecting 
lymphatics is the portal vein. Like the portal vein, collecting lymphatics were more 
sensitive to the rate rather than to the magnitude of circumferential stretch (33, 58). These 
characteristics are consistent with developmental work showing that lymphatic 
endothelial cells are derived from the cardinal vein (114). In experiments where isolated 
mesenteric collecting lymphatics were exposed to pressure ramps of different rates, bursts 
of increased contraction frequency were observed with increasing hydrostatic pressure 
ramps while inhibition of contraction frequency was observed for ramps decreasing 
pressure (33). When the effects of substance P on collecting lymphatic sensitivity to 
stretch were assessed, both contraction amplitude and frequency were enhanced under 
basal conditions and in response to elevations in pressure (4, 31).  
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The molecular basis for lymphatic spontaneous contractions has just begun to be 
explored. Nitric oxide (NO) has been implicated in the modulation of collecting 
lymphatic spontaneous contractions (38). Application of NO to the solution bathing 
isolated collecting lymphatics blunted spontaneous contraction frequency, amplitude, and 
ejection fraction in a fashion that imitated the effects of lymph flow. However, when the 
effect of elevated flow was investigated after the addition of the NO synthase inhibitor, 
L-NAME, NO did not fully account for the inhibition of contraction amplitude and 
frequency. NO involvement in the regulation of lymphatic spontaneous contractions is 
discussed in more detail in a recent review (141).  
Importantly, calcium has been studied in the context of lymphatic phasic activity. 
Several different Ca2+ channels have been identified in lymphatic muscle, including L-
type and T-type channels (49). A hypothesis for spontaneous transient depolarizations 
(STD) in the generation of spontaneous contractions has been proposed (131). At present 
it is likely that summation of several STD leads to a spontaneous contraction, with 
several ion channels appearing to be involved (131, 134). Another hypothesis states that 
pacemaker cells generate a current which spreads throughout the lymphatic muscle (89). 
The precise location of these cells, though, was made difficult by the diffusion of current 
(64). A newer study, however, has identified a subpopulation of lymphatic muscle cells 
that may act as pacemaker cells (76). While evidence for the sympathetic innervation of 
lymphatic muscle is abundant, its role in altering spontaneous contractions has not been 
fully investigated. Several current reviews cover this topic in greater detail (78, 128, 131, 
141).  
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The benefits of studying the mechanisms of lymphatic contractions are obvious – 
during edema, when the lymphatic vessels appear overwhelmed, an increase in pumping 
efficiency would be expected to recover proper fluid balance.  
 
Lymphatic Solute Permeability 
Many studies have probed the ‘solute permeability’ of initial lymphatics in a 
qualitative fashion, in that absolute values of permeability were not measured directly. 
Instead, after injection of colloid or radiolabeled protein, inferences were made from 
visualizing tracer uptake, analyzing downstream lymph samples, or viewing histological 
sections. As previously stated, both interendothelial pores (70) and transendothelial 
vesicles (1, 70) have been implicated in solute and fluid removal from the interstitium by 
initial lymphatics. The physiological role for vesicles in the lymphatic vasculature 
remains unknown, but their appearance may reflect the anatomic variation in lymphatic 
morphology (41). Leak (70) favored the view that the interendothelial route was the 
major conduit for solute transport, whereas vesicles facilitated digestion of interstitial 
protein by the initial lymphatic endothelium. Generally, it is now believed that initial 
lymphatics are able to passively absorb particles, protein, cells, and fluid from the 
interstitium through large pores without regard for molecular size. Consequently, the 
lymph protein concentration of initial lymphatics probably approximates the protein 
concentration of the interstitium (120, 140). Much controversy still surrounds the 
question of whether the protein concentration of lymph from collecting lymphatics is 
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equal to that of interstitial fluid; i.e., whether collecting lymphatics possess the ability to 
concentrate solute along their length (17, 56, 119, 120).  
Unlike initial lymphatic solute uptake, flux of solute across the collecting 
lymphatic walls depends on molecular size (75). Studies performed by Mayerson (75) 
were initially aimed at answering questions regarding blood capillary permeability, using 
the lymphatic circulation as a “window into the interstitium,” but became focused on how 
efficiently lymph is transported through the lymphatic vessels. By injecting a known 
amount of radiolabeled albumin directly into a canine limb collecting lymphatic duct (of 
unknown diameter, but likely much larger than the peripheral collecting lymphatics, 
which average ~100 µm) and analyzing thoracic duct lymph, the percent albumin lost 
across the vessel wall was estimated (94). Not only is this method less sensitive than 
microfluorometric methods used today (50), but it almost certainly reflects the 
‘permeability’ of the larger collecting lymphatic ducts and lymph nodes, not the prenodal 
microlymphatics or collecting lymphatic vessels. However, these studies were novel for 
the time and provided a first approximation of the size selectivity of the lymphatic ducts 
up to and including the thoracic duct. What Mayerson (75) discovered was that 
macromolecules equal to or greater than 6000 daltons (6 kDa) did not leave the larger 
ducts in ‘great’ quantity (albumin lost < 3%), while molecules smaller than 6 kDa 
escaped the vessels with ease. Simply put, large lymphatic ducts seemed to possess a 
relatively low ‘permeability’ to large macromolecules and a higher ‘permeability’ to 
molecules smaller than insulin.  
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Physiological Importance of Maintaining Lymph Flow 
As summarized by Drinker (36), the main function of the lymphatic vasculature is 
to be: 
“…engaged steadily in returning blood proteins to the blood, and that in 
the absence of normal lymph function these substances will accumulate 
extravascularly.” 
Therefore, because approximately 50% of the plasma proteins are filtered by the blood 
microvessels per day, and are not reabsorbed by the venules (72, 82), the lymphatic 
circulation alone is left with the task of returning these proteins to the blood (41, 100). 
Extravascular accumulation of plasma proteins, if unchecked, leads to the osmotic flow 
of water into the interstitium, producing edema. Further, Drinker (36) found that if 
thoracic duct lymph flow is diverted into a test tube, then the blood microvasculature 
“simply converts all the plasma to lymph.” Such a circumstance is not compatible with 
life and illustrates the importance of a properly functioning lymphatic vasculature that 
returns protein and fluid to the blood. 
In reality the extreme circumstance of stopping systemic lymph flow is rarely 
encountered, but several other mechanisms are known to diminish regional lymph 
transport: vessel regression or damage (including radiation and surgical transection), 
valvular incompetence of the collecting lymphatics, vessel obstruction either by parasites 
(filariasis) or cancer cells (metastasis), and inhibition of spontaneous contractions (e.g., 
by calcium channel blockers (15)). Because lymph flow is needed to return plasma 
proteins and water to the blood circulation, these events cause a backup of the capillary 
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filtrate into the interstitium. Eventually, sufficient fluid accumulates in the interstitium to 
increase the interstitial hydrostatic pressure until it matches the capillary pressure and 
water ceases to be filtered into the interstitium. Solute continues to diffuse down its 
concentration gradient into the interstitium until the protein concentration matches that of 
the blood flowing through the capillaries. When this occurs, fluid and solute are at 
equilibrium between the interstitium and blood. This type of edema is called 
“lymphedema”, as it originates from a deficiency in lymphatic function.  
However, another mechanism exists that could reduce lymph flow enough to 
produce lymphedema – a change in lymphatic vessel permeability to water and solute. 
Here the phrase ‘lymphatic permeability’ is meant to be analogous to that of blood 
microvessels because it refers to the permeability of the lymphatic vessel endothelium, 
not the permeability of the large initial lymphatic pores as is commonly assumed. As the 
permeability of the collecting lymphatic vessels to protein is the focus of this dissertation, 
the next section will explain how alterations in lymphatic permeability would be expected 
to lead to a diminished lymph flow.  
 
Microvessel Solute Permeability Theory 
To explain how Mayerson’s observations (75) differ from direct measures of 
permeability, we must first understand what ‘permeability’ means. The terminology here 
will be the same as that used for the blood microvessels (50).  
The diffusion of a solute across a semi-permeable membrane is described by 
Fick’s first law:  
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Ps = Js/S∆C,                                          (1.1) 
where membrane permeability to a solute (Ps, cm⋅s-1) is defined by the rate at which 
solute crosses the membrane (solute flux, Js, mmol⋅s-1) over its finite surface area (S, 
cm2) with a constant concentration gradient between the two sides of the membrane (∆C, 
mmol⋅mL-1). This relationship accurately describes the diffusional permeability of a 
vessel to a solute in the absence of a hydrostatic pressure gradient across the vessel wall. 
Blood vessels, however, have both hydrostatic and oncotic pressure differences across 
their walls, with the net effect of filtering water into the interstitium. If water and solute 
share the same pathway, then water movement can force solute across the vessel wall 
faster than it would occur by diffusion alone. The name for this process is convective 
transport and can lead to a pressure-dependent increase in solute flux.  
A separate relationship describes the movement of water across the blood vessel 
wall. In 1896 Starling (116) hypothesized that the balance of two forces (P, hydrostatic 
pressure; and π, oncotic pressure; both in cmH2O) determine water flux (Jv, mL⋅s-1) 
leading to the modern day form of the Starling equation: 
Jv/S = Lp[∆P - σ∆π],                                                (1.2) 
where ∆P and ∆π refer to the differences in hydrostatic and oncotic pressures, 
respectively, between the blood vessel lumen and the interstitium. The probability that a 
solute traveling towards the vessel wall will pass through or be reflected back into the 
lumen is denoted by the reflection coefficient, σ , and is a value between 0 and 1. If a 
protein were to have a reflection coefficient of 0, every molecule encountering the wall 
would pass through to the interstitium so that no oncotic pressure difference would be 
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observed. Conversely, if the reflection coefficient were 1 for a protein, then every 
molecule would be retained in the lumen, water could move, and the full oncotic pressure 
difference would be exerted across the wall. In actuality, the value is between 0 and 1 for 
proteins so that some fraction of the oncotic pressure is expressed (i.e., effective oncotic 
pressure). For the macromolecule albumin, this value is in the range of 0.85 – 0.95 
depending on the animal species, vessel type, or charge of the protein. The Lp term in 
Equation 2 is a measure of the porosity, or permeability, of the vessel wall to water and is 
called hydraulic conductivity (Lp, cm⋅s-1⋅cmH2O-1).  
Equation 1.1, then, is an incomplete description of all the forces involved in solute 
flux across the endothelial barrier. We can rewrite the equation to include the convective 
component of solute flux as: 
Ps = Js/S∆C = Pd[Pé/(ePé – 1)] + Jv/S(1 - σ),                             (1.3) 
where Ps is the apparent permeability to solute (at a particular hydrostatic pressure), Pé 
stands for the Péclet number, a (unitless) ratio between the convective and diffusive 
driven solute flux. Specifically, the ratio is defined as: 
Pé = [(Jv/S)(1 - σ)] / Pd.                                             (1.4) 
The other new term introduced in Equations 1.3 and 1.4 is the diffusional permeability 
(Pd, cm⋅s-1), and is defined as the permeability measured when only diffusion is driving 
solute flux; i.e., when no other forces, such as convection, are present.  
Returning now to Mayerson’s experiments (75), we can see that his observations 
cannot suffice as substitutes for permeability measurements because changes in pressure, 
surface area, or concentration could result in changes in solute flux that have no 
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corresponding physiologically relevant meaning relative to the structure of the exchange 
barrier, whereas changes in permeability accurately reflect physiological processes that 
alter the rate at which solute crosses the endothelial barrier. What he was really 
measuring was the amount of solute lost per unit time and is equivalent to Js (mmol⋅s-1). 
To calculate permeability, he would have needed three additional pieces of information – 
the surface area of the vessel, the concentration difference across the vessel wall, and the 
pressures of the vessel where the solute was lost. Thus, we can see from Equation 1.3 that 
while several extraneous factors could alter falsely a measure of solute flux, permeability 
measurements are inherently more accurate at describing solute movement as they 
account for pressure, convection, surface area, and solute concentration.  
Typically, solute leaks from the blood microvessels down its concentration and 
pressure gradient; i.e., the solute concentration is greater in the vessel lumen than in the 
interstitium (see Eqn 1.1). For most plasma proteins this is the case and they leak into the 
tissue spaces, albeit slowly. However, the concentration gradients for proteins in lymph 
have not been established throughout the lymphatic vessel network, making it difficult to 
know whether increasing permeability to a solute will result in a faster transport of solute 
into or out of the vessel. 
 
Natriuretic Peptides and their Influence on Microvascular Permeability 
The natriuretic peptides are peptide hormones secreted predominantly either by 
the heart or by the vascular endothelium with the net effect of reducing cardiovascular 
volume. Multiple isoforms are secreted by the heart – atrial natriuretic peptide (ANP) is 
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secreted mainly by the atria and the majority of brain natriuretic peptide (BNP) is 
secreted by the ventricles. Precursor proteins are cleaved to give rise to both active 
isoforms whose plasma concentrations increase in response to myocardial stretch. The 
third isoform, C-type natriuretic peptide (CNP), is produced by and acts on the 
endothelium in an autocrine manner. The actions exerted by ANP are well documented 
and include natriuresis and inhibition of the renin-angiotensin-aldosterone axis, which 
serve to reduce the vascular volume (101). This is particularly important in lowering 
vascular volume in response to vascular volume expansion or fluid shifts (e.g., 
microgravity and congestive heart failure).  
ANP has also been reported to increase the vascular permeability of microvessels 
to water and solute (51, 80). By increasing vascular permeability, both water and protein 
leave the vasculature faster with the effect of displacing some of the vascular volume into 
the interstitium. Another name for this process is “third-spacing,” as the interstitium 
represents the third compartment in the body, after the vascular and cell compartments. 
When capillary and venular responses to ANP were compared, no difference in 
sensitivity was observed (53). While the effects of BNP on mammalian microvessel 
permeability were never tested, the permeability responses of frog capillary venules to 
BNP is similar to that of ANP (79). 
An important question to answer is whether ANP or BNP alter lymphatic vessel 
permeability to either solute or water, since the lymphatic vessels are important in 
regulating fluid homeostasis. One recent study provides evidence that upon ANP infusion 
into the splenic artery, extrasplenic lymphatic solute flux increased (18), suggesting that 
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these peptides may target the lymphatic circulation as an additional mechanism to reduce 
cardiovascular volume.  
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Hypotheses 
The most recent understanding of lymphatic permeability has been presented, 
demonstrating that several important questions remain to be answered. Are lymphatic 
vessels absorptive, leaky, or perhaps are they impermeable as textbooks propose? Would 
an increase (or decrease) in lymphatic permeability be expected to resolve or create 
edema? Does lymphatic permeability change significantly in response to vasoactive 
agents known to alter vessel tone or in any cardiovascular diseases? Are there regional 
differences in lymphatic permeability (e.g., between micro- and collecting lymphatics)? 
Do collecting lymphatics really concentrate solute along their length? 
The current dissertation answered several of these questions by testing the 
following two hypotheses based on the fact that lymphatic endothelial cells originate 
from the venous endothelium (114) and the inference that functional similarity exists 
between the lymphatics and venules: 
 
1) The collecting lymphatic permeability to albumin will not differ from that of venules 
in the same tissue. 
 
2) A vasoactive peptide hormone encountered during volume expansion/shifts as occurs 
in congestive heart failure (specifically, 100nM atrial or brain natriuretic peptide) known 
to increase venular permeability to albumin will elevate collecting lymphatic vessel 
permeability to albumin to a similar magnitude and with similar kinetics. 
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CHAPTER 2: IN VIVO DETERMINATION OF COLLECTING LYMPHATIC 
VESSEL PERMEABILITY TO ALBUMIN: A ROLE FOR LYMPHATICS IN 
EXCHANGE 
 
Abstract 
While it is well established that the lymphatic vasculature is central to fluid and solute 
homeostasis, how it accomplishes this task is not well defined. To clarify the basic 
mechanisms underlying basal fluid and solute homeostasis, we assessed permeability to 
rat serum albumin (PsRSA) in mesenteric collecting lymphatic vessels and venules of 
juvenile male rats. Using the quantitative microfluorometric technique originally 
developed for blood capillaries, we tested the hypothesis that as a consequence of venules 
and collecting lymphatics sharing a common embryological origin, their PsRSA would not 
differ significantly. Supporting our hypothesis the median collecting lymphatic PsRSA 
(3.5±1.0 x10-7 cm⋅s-1, N=22) did not differ significantly from the median venular PsRSA 
(4.0±1.0 x10-7 cm⋅s-1, N=8, p=0.61). For collecting lymphatics the diffusive permeability 
(Pd = 2.5 x10-7 cm⋅s-1) was obtained from the relationship of apparent PsRSA and pressure. 
While the measured PsRSA, Pd, and estimated hydraulic conductivity of collecting 
lymphatics and venules were similar, the contribution of convective coupling differs as a 
result of the higher hydrostatic pressure experienced by venules relative to collecting 
lymphatics in vivo. In summary, the data demonstrate the capacity for collecting 
lymphatics to act as exchange vessels, able to extravasate solute and filter fluid. As a 
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consequence these data provide experimental support for the theory that prenodal 
lymphatic vessels concentrate intraluminal protein.  
 
Introduction 
The lymphatic system is known to be vital for fluid homeostasis, lipid absorption, 
and immune surveillance under conditions of health (41, 74, 75). Less widely understood 
is the role of the lymphatic system in disease states such as edema, inflammation, cancer, 
and obesity (2, 46, 115). A recent upsurge in interest, likely reflecting the development of 
novel molecular markers specific for lymphatic vessels and realization of their 
importance to disease, has led to significant advances in this field (26). Knowledge of 
lymphatic vessel function, though, still lags behind that of the blood vessels given the 
difficulty in studying these structures that are sensitive to both mechanical and chemical 
stress (75). While lymphangiogenesis, lymphatic pumping, and lymph node function are 
receiving current attention, other elusive aspects of the lymphatic system that deserve 
attention still remain.  
One aspect of lymphatic function relates to its role in exchange, in particular, 
lymphatic vessel permeability to solute. Lymphatic permeability was studied in the 1960s 
predominantly as a means for gaining insight into blood capillary permeability. The few 
experiments performed during that era concluded that the lymphatic system retains all 
solutes with molecular weights larger than 2300-6000 (75). Because radiometric methods 
used at that time had limited sensitivity compared to present day microfluorometric 
methods that facilitate quantitative measurement of solute flux in living tissue (51), we 
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decided to use the latter approach to test the hypothesis that lymphatic vessels possess a 
macromolecular permeability analogous to that of the blood microvessels, particularly 
venules, under basal conditions.  
Blood microvessels are permeable to solute and water. In health, microvessel 
permeability is influenced by tissue function and can be modestly regulated both 
positively and negatively. Microvessels possess a barrier of finite permeability to provide 
adequate perfusion of the tissues with nutrients, oxygen, and lipids. However, it is widely 
taught that the processes controlling exchange, whether water or solute, are passive and 
that only under inflammatory states does permeability change – usually an increase 
whereupon materials contained in the vascular compartment leak into the tissue space, 
thereby compromising function. Furthermore, microvascular exchange has been 
represented pictorially in multiple texts by a single exchange vessel, a capillary, 
connecting a single arteriole with a single draining venule (13, 16). In this oversimplified 
model, filtration of fluid occurs on the arterial (high pressure) end of the capillary and 
reabsorption of 90% of this filtrate occurs on the venous side of the capillary (16, 43). In 
opposition to this view, many experimental studies have provided evidence that filtration 
occurs throughout the microvascular network of vessels, with reabsorption only occurring 
during special states (e.g., increased tissue hydrostatic pressure) or in encapsulated organs 
(72, 82, 100). Appreciation of this discrepancy is important because the mental picture of 
a single capillary replacing a microvessel network obscures the clinically important role 
that the missing constituents, the lymphatic vessels, play in the establishment and 
maintenance of proper fluid homeostasis. Thus, the fact that the microvessels filter 
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approximately 50% of the circulating plasma proteins per day – all of which is returned 
to the circulation by the lymphatic system – reinforces this assertion (36, 41, 100).  
The focus of this manuscript, the collecting lymphatic vessels, share important 
features with veins, including presence of valves, smooth muscle, and chronic exposure 
to a low hydrostatic pressure environment. Notably, the developmental origin of 
lymphatic endothelium has recently been shown to be the veins (114). Given their 
morphological similarity and common embryological origin, we hypothesized that the 
permeability of collecting lymphatic vessels and venules to albumin would not differ in a 
given tissue. Additionally, given that collecting lymphatics exhibit a greater hydrostatic 
pressure than microlymphatics, we posited that collecting lymphatics were a potential site 
for solute exchange (143). Here, for the first time, we measure basal permeability values 
to rat serum albumin for in vivo rat mesenteric collecting lymphatics. To accomplish this 
task we developed and validated a reliable method for cannulation and perfusion of 
collecting lymphatics in rat mesentery.  
From measurements of albumin flux at multiple hydrostatic pressures, we 
determined the diffusive permeability to albumin (Pd) and the convective coupling of 
albumin flux to transmural fluid flux of collecting lymphatic vessels from rat mesentery. 
Utilizing these data, estimates of volume flux of the collecting lymphatics over a range of 
physiological pressures were determined. We found, consistent with our hypothesis, that 
permeability to albumin does not differ between venules and collecting lymphatic 
vessels. Preliminary results from this study have been presented in abstract form (109).  
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Methods 
Ethical Approval:  
Animal protocols were approved by the Institutional Animal Care and Use 
Committee (IACUC) at the University of Missouri and conducted in accordance with the 
National Institutes of Health’s Guide for the Care and Use of Laboratory Animals. All 
animals were killed after the experiment by an overdose of anaesthetic followed by 
bilateral pneumothorax and aortic transection in agreement with the protocol.  
 
General Surgical Preparation:  
All experiments were performed in situ on juvenile male (35-55 days, 200-250g) 
Sprague Dawley rats (Hilltop Lab Animals, PA, USA) housed 3 to a cage for a minimum 
one-week acclimation period prior to the experiment. For these initial studies, juvenile 
males were chosen for their lack of visceral fat, which facilitated location and subsequent 
cannulation of collecting lymphatics. One venule or collecting lymphatic was cannulated 
per animal.  
Following induction of anesthesia with Inactin (IP, thiobutabarbital, Research 
Biochemicals Int., MA, USA, 128 mg/kg body weight), surgical exteriorization of the 
mesentery and continuous superfusion (2-3 mL/min) with mammalian Krebs at 37 ± 
0.5°C, a vessel was located under the Zeiss dissection microscope. The animal on a 
custom, heated Plexiglas™ board was then transferred to a Leitz Diavert inverted 
microscope and the suffused preparation was allowed to equilibrate for approximately 30 
minutes prior to vessel cannulation and data collection.  
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Venular and Lymphatic Microvessel Classification: 
To facilitate comparison of our data with previously published measurements of 
mammalian venular permeability (104, 107), only relatively straight, unbranched venules 
with brisk flow and fewer than 2 adherent leukocytes were used. Vessels enveloped by 
adipose tissue were avoided because the fat cells make cannulation nearly impossible. 
Venules were identified by size, paucity of smooth muscle, and converging flow on either 
side of the vessel segment as described by Chambers and Zweifach (22). Collecting 
lymphatic vessels were identified by the presence of valves, spontaneous contractions, 
and their transparent contents (143). Leukocytes were often visualized in collecting 
lymphatics, which were not studied if more than 2 adherent cells were seen.  
 
Solutions:  
Mammalian Krebs. All superfusion and perfusion solutions were prepared fresh 
and used on the same day. Unless otherwise stated all materials were purchased from 
Sigma (MO, USA). The Krebs solution consisted of (in mmol): 141.4 NaCl, 4.7 KCl, 2.0 
CaCl2⋅2H2O, 1.2 MgSO4, 1.2 NaH2PO4⋅H2O, 5.0 d-glucose, 3.0 NaHCO3, and 1.5 
NaHEPES. The pH of the solution was 7.4 ± 0.05 at 37°C.  
Krebs-BSA. Dialyzed (Supplemental Methods) bovine serum albumin (BSA, 
Sigma cat# A7906) was added to the Krebs solution to achieve a final concentration of 1 
mg/mL on the day of the experiment. The osmolarity, measured by freezing point 
osmometry, was generally between 292-297 mOsm after the addition of BSA. 
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Labeled Protein. The macromolecular probe used in this study, rat serum albumin 
(RSA, Sigma cat# A6272), was bound to the Alexa-488 fluorophore (Invitrogen, CA, 
USA) by modifying the manufacturer’s protocol (see Supplemental File). The perfusate 
solution contained 10% (w/v) labeled RSA (1 mg) with 9 mg of unlabeled RSA and was 
brought to a volume of 1 mL with freshly made Krebs solution so that the final total 
protein concentration was 10 mg/mL. A washout solution was made, with unlabeled 
protein, at an identical total protein concentration. Both solutions of 10 mg/mL RSA 
possessed an oncotic pressure of 4.1 cmH2O calculated from the Landis-Pappenheimer 
equation (67).  
 
Assays for Total Protein and Albumin Concentration of Lymph: 
The concentration of albumin and total protein were measured in samples of 
lymph, peritoneal fluid, and plasma (N=4). Lymph was obtained after cannulation with 
an empty siliconized single lumen micropipette (tip diam. = 25 µm) of collecting 
lymphatic vessels in rat mesentery covered with mineral oil. Peritoneal fluid was 
obtained by swabbing the mesentery with a hematocrit tube immediately following the 
midline incision. Approximately 20-60 µL of blood-free lymph and peritoneal fluid were 
obtained using these methods. Plasma was obtained by centrifuging ~3 mL of blood 
(taken by intracardiac puncture) for 10 minutes at 3220×g.  
Total protein concentration of each sample was determined (Supplemental File) 
by the Micro BCA Protein Assay, while albumin concentration was determined by the 
Albumin Blue 580 Fluorescence assay (62). All solutions were made fresh on the day of 
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use. The albumin or total protein concentration was then used to calculate the albumin or 
total protein oncotic pressures, respectively, for each sample using the Landis-
Pappenheimer equations (67).  
 
Measurement of Microvessel Protein Flux:  
The method for determining solute permeability (Ps) to proteins in mammalian 
blood microvessels and its limitations is described in several publications (50, 104, 107). 
In short, collecting lymphatics and venules studied here were cannulated with custom 
made pipettes and perfused with either fluorescently labeled RSA (dye) or unlabeled 
RSA (washout) in Krebs solution. Details of the pipette fabrication and cannulation 
procedures are to be found in the Supplemental Methods. In experiments using theta 
pipettes the vessel was perfused at constant, selected pressures under user control. 
Switching a valve changed the perfusate from the washout solution to the dye solution for 
a time sufficient to make measurements of fluorescence intensity without altering 
pressure. Additionally, this system allowed the native vessel pressure (PLumen, Table 1) to 
be measured prior to assessment of solute flux by keeping the fluorescent dye front from 
moving within the pipette. Pressure in spontaneously contracting collecting lymphatics is 
constantly changing so only diastolic pressure (during relaxation) was recorded. 
Importantly, one must understand that these native pressure measurements (Table 1) were 
made before measuring solute flux to establish the native pressure range for collecting 
lymphatics. To measure solute flux the pipette pressure was raised above that of the 
vessel in order to elicit flow of the perfusate. During the solute flux measures, the 
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perfusion pressure of the theta pipette was measured when there was zero flow through 
the non-perfusing side. This pressure was plotted in Fig. 5, but was not reported in Table 
1.  
Direct measures of solute flux (Js, mmol/s) were made over an area of vessel 
defined by a rectangular diaphragm (width ≥4 vessel diameters, length = 8 vessel diam.). 
When dye labeled solute filled the vessel lumen there was an initial step increase in 
fluorescence intensity (Io), followed by a gradual, but linear, increase in intensity as 
fluorescent probe accumulated in the interstitial space over time (dIf/dt) in addition to the 
signal generated from the fluorophore flowing through the vessel lumen. Apparent solute 
permeability (Ps, cm⋅s-1) was calculated from the equation relating solute flux (Js, mmol⋅s-
1) to surface area (S, cm2) at a constant concentration difference (ΔC, mmol⋅mL-1)(50):  
Ps = Js/SΔC = (1/Io)(dIf/dt)(D/4)                                         (2.1). 
Vessels were assumed to be circular and to have a volume-to-surface area ratio of D/4.  
Triplicate measures of flux were attempted in each vessel. In some vessels solute 
flux was measured at different hydrostatic pressures to assess the relationship between 
convective and diffusive flux. Previously, we and others (27, 50) have shown that when 
convective water movement contributes to Js, measures of Ps overestimate the true 
diffusive permeability (Pd). These terms are related by the equation:  
Ps = Js/SΔC = Pd[Pé/(ePé – 1)] + Jv/S(1 - σ)                                (2.2), 
where Pé is the Péclet number: 
Pé = [Jv/S(1 - σ)]/Pd                                                  (2.3). 
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Eqn. 2.2 is a modified form of the Patlak, Goldstein, and Hoffman equation (93). 
Assuming a homoporous barrier and a small constant interstitial oncotic pressure, 
Ps = Js/SΔC = Pd[Pé/(ePé – 1)] + Lp(1 - σ)(∆P - σ∆π)                    (2.4), 
where ΔP (cmH2O) is the hydrostatic pressure difference between the vessel lumen and 
the interstitium (Pc – Pi), Lp is the hydraulic conductivity (cm⋅s-1⋅cmH2O-1), σ is the unit-
less reflection coefficient for solute, and Δπ (cmH2O) is the oncotic pressure difference 
(πc – πi) exerted across the vessel wall. Plotting Ps against hydrostatic pressure and 
simultaneously solving for Pd and Lp(1 - σ) from Eqn. 2.4 yields a curve describing the 
data. When the net filtration pressure (ΔP - σΔπ) is equal to zero, the y-intercept becomes 
Pd. The limiting slope of this line is Lp(1 - σ) and labeled in Fig. 5 (52).  
Volume flux (Jv, cm3⋅s-1) across a semipermeable membrane of surface area (S) is 
described by the modern form of the Starling equation:  
Jv/S = Lp(ΔP - σΔπ)                                                  (2.5), 
where Lp, ΔP, σ, and Δπ are as defined above. However, this equation describes Jv during 
transient (i.e., when pressure is changing) rather than steady state conditions. Another 
equation has been developed that describes steady state Jv (82):  
Jv/S = Lp[ΔP - σ2πc(1 – e-Pé)(1 - σe-Pé)-1]                            (2.6a). 
Eqn. 2.6a can be rewritten to group the unknown terms on one side of the equation: 
 ΔP = (Jv/LpS)+ σ2πc(1 – e-Pé)(1 - σe-Pé)-1                            (2.6b), 
where πc is the colloid osmotic pressure in the vessel. Neither eqn. 2.5 nor 2.6 assume 
large hydrostatic pressures or large Pé values.  
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Statistical Analyses: 
Prism™ (GraphPad Software, CA, USA) software was used for all statistics. To 
determine whether the Ps to albumin (PsRSA) in collecting lymphatic vessels differed 
significantly from the venular PsRSA, the nonparametric Mann-Whitney U test was 
performed at a 95% confidence level to compare the medians because data from both 
groups were left skewed (i.e., not normally distributed). Distribution normality was 
determined by the D’Agostino-Pearson K2 test. The Kolmogorov-Smirnov Two Sample 
test was performed (30) to compare the distributions of collecting lymphatic and venular 
PsRSA values with 95% confidence. To compare the medians of all three skewed data sets, 
the nonparametric one-way ANOVA Kruskal-Wallis test was performed at a 95% 
confidence level. Medians were reported as median ± median absolute deviation (MAD). 
Means were compared with the Student’s unpaired t-test and reported as means ± 
standard error (SE) to compare the present permeability data with published values. For 
comparisons of total protein and albumin concentration differences between peritoneal 
fluid and lymph, Student’s paired t-tests were performed and the means ± standard error 
(SE) were reported.  
Power analysis performed beforehand indicated that to detect a 20% change 
between the two groups (1 x 10-7 cm⋅s-1), with a 95% confidence (significance level 
P<0.05), approximately 21 animals were needed in each group (86). 
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Results 
Raw Tracings of Solute Flux 
Figure 3 illustrates a raw data tracing of the fluorescence intensity of the probe 
(Alexa-488 conjugated RSA) as a function of time from experiments on two separate 
animals. The tracing on the left is from a collecting lymphatic vessel perfused at a 
pressure of 5 cmH2O and the tracing on the right is from a similar vessel perfused at a 
pressure of 15 cmH2O. Visible spontaneous contractions, shown in the expanded view as 
fluctuations in the fluorescence intensity, are evident from tracing A, while tracing B 
lacks these fluctuations. Both patterns were encountered in the present study only after 
cannulation, since prior to cannulation all collecting lymphatic vessels exhibited 
spontaneous contractions.  
Basal Albumin Permeability of Collecting Lymphatics and Venules 
Table 1 reports the apparent albumin permeability values (PsRSA) of all vessels in 
this study along with their respective native pressure and diameter measurements. The 
PsRSA of collecting lymphatics and venules did not differ significantly whether analyzed 
as means (p = 0.80, 5.0±0.9 x 10-7 cm⋅s-1 (N=22) vs. 4.6±0.9 x 10-7 cm⋅s-1 (N=8)) or 
medians (p = 0.61, 3.5±1 x 10-7 cm⋅s-1 vs. 4.0±1 x 10-7 cm⋅s-1) consistent with our 
hypothesis. As anticipated from the work of Zweifach & Prather (143), collecting 
lymphatic native pressure (PLumen) correlated with diameter (p = 0.03, Table 1). When 
PLumen and diameter of collecting lymphatics was compared to that of venules, lymphatic 
pressure was significantly lower (p < 0.0001) and diameter was significantly greater (p < 
0.0001).  
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Comparing frequency distributions for all 22 collecting lymphatic PsRSA values 
reported in Table 1 (Fig. 4A) and 26 rat mesenteric venular PsRSA values (Fig. 4B) (102, 
104) provides additional support for the hypothesis. Both frequency distributions were 
strikingly similar and left skewed. The Kolmogorov-Smirnov Two Sample test (30) 
concluded that these two distributions did not differ (p = 0.37). Since the distributions are 
not statistically normal (p < 0.0001), it is more accurate to compare the medians instead 
of the means of the two populations (86, 104). The Mann-Whitney U test was performed 
and demonstrated that the median collecting lymphatic (PsRSA = 3.5±1 x 10-7 cm⋅s-1, 
N=22) and median venular (PsRSA = 5.6±2 x 10-7 cm⋅s-1, N=26) values for albumin 
permeability did not differ significantly (p = 0.12). When we tested for any differences 
between all three groups by performing the Kruskal-Wallis test, none were observed (p = 
0.24). Finally, when we compared our measured venular values to those previously 
reported (102, 104), we discovered that they did not differ (p = 0.31).  
Convective Coupling of Albumin Flux 
All apparent PsRSA values from collecting lymphatics were graphed in Fig. 5 to 
illustrate the dependence of solute flux on hydrostatic pressure. The dashed line 
demarcates the effective osmotic pressure (σΔπ = 3.85 cmH2O) of the perfusion solution 
when σ is 0.94. Where it meets the solid line is the true diffusive permeability to albumin 
(Pd = 2.5 x 10-7 cm⋅s-1). The limiting slope of the solid line is equal to Lp(1 - σ) = 1.3 x 
10-8 cm⋅s-1⋅cmH2O-1, and is used to calculate the Péclet number. Additionally, the Lp of 
the pathway conducting both solute and water can be estimated from this term if σ is 
known.  
  39 
 
 
 
  
40 
 
 
  41 
Predicted Solute and Volume Flux from the Albumin Concentration of Lymph and 
Peritoneal Fluid 
Figure 6 (from Table 2) summarizes the measured albumin and total protein 
concentration of lymph, peritoneal fluid, and plasma from 4 animals. The calculated 
oncotic pressures for total protein and albumin, given for each compartment, were then 
used to predict the relationships illustrated in Fig. 7.  
Predicted solute flux per unit surface area per concentration difference (Js/S∆C) 
was plotted over pressure in Fig. 7A. To accomplish this Pd and Jv/S (obtained below) 
were substituted into Eqn 2.2. The limiting slope of this line is equal to Lp(1 - σ).  
The volume flux per unit surface area (Jv/S) as a function of pressure was 
predicted for transient and steady state conditions by substituting Pd and Lp into Eqns. 2.5 
and 2.6b (shown in Fig. 7B). The calculated oncotic pressure difference for albumin (Δπ) 
was substituted into Eqn. 2.5, while the calculated oncotic pressure of lymph albumin 
(πL) was appropriately substituted into Eqn. 2.6b. Both the steady state and transient state 
curves are shown over a wide range of pressures. The x-intercepts correspond to the 
transmural effective oncotic pressures and are labeled. The limiting slope of all lines is 
equal to Lp.  
 
 
 
 
 
  42 
 
 
 
 
 
  
43 
 
 
  44 
Discussion 
The present study was a test of the null hypothesis that the albumin permeability 
of collecting lymphatic vessels would not differ from venules. To our surprise we 
accepted our hypothesis, since the Ps medians between the two groups did not statistically 
differ. Additionally, we noted a remarkable similarity in the distributions of the data sets, 
which were both left skewed. From the plot of apparent permeability data over pressure 
we were able to estimate the true diffusive permeability (Pd) to albumin of rat mesenteric 
collecting lymphatics.  
Methodological Limitations for the Measurement of Solute Flux 
Measurement of solute flux is determined from the step change in fluorescence 
intensity upon filling of the vessel and subsequent change in intensity over time.  This 
measurement could be compromised if there were to be photobleaching of the dye during 
the measurement period.  Further, photobleaching of the dye is associated with free 
radical formation, which itself could alter barrier properties. 
Photobleaching of the fluorescent probe was evaluated on the same equipment as 
used for experiments by exciting a sample of the conjugated probe on a standard glass 
slide with a spacer (thickness of 150-microns) and coverslip. Emission of the fluorescent 
probe, measured over 4 hours of constant excitation in vitro, did not vary, demonstrating 
the photostability of this labeled macromolecular probe. During experiments in vivo the 
longest time the interstitial probe was excited was 30 minutes; probe in the vessel lumen 
was only excited for seconds because flow carried it out of the measuring window. 
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All experiments were performed on juvenile male rats (< 60 days) to take 
advantage of their lack of perivascular adipose tissue. To calculate the effective oncotic 
pressure for the perfused albumin solution, σ of albumin must be known for collecting 
lymphatics. Because this value has never been measured we assumed that it was equal to 
that of rat mesenteric venules (0.94, (61)). Finally, for all graphs of flux we assumed that 
Pi was equal to an atmospheric pressure of zero.  
Similarity of Collecting Lymphatic and Venular Permeability 
The median collecting lymphatic PsRSA (3.5±1 x 10-7 cm⋅s-1) did not differ 
significantly from the PsRSA of venules in this study (4.0±1 x 10-7 cm⋅s-1) or venules from 
a previous study (5.6±2 x 10-7 cm⋅s-1, (104)). Strikingly, even the frequency distributions 
of lymphatic and venular Ps did not differ (Fig. 4). No correlation was observed between 
PsRSA and vessel diameter or time of year, ruling out seasonal variation of solute 
permeability in the rat (data not shown). However, as for venules, a correlation was found 
between collecting lymphatic PsRSA and the perfusion pressure at the time of the flux 
measurement, a result of the coupling of solute flux to volume flux.  
When the PsRSA values are graphed against hydrostatic pressure, one can 
determine the true diffusive permeability (Pd) under the special condition of zero net 
filtration pressure. We found that collecting lymphatic Pd was 2.5 x 10-7 cm⋅s-1 after 
adjusting the graph for the effective osmotic pressure of our perfusate. While not very 
different from the Pd to bovine serum albumin (BSA) for frog mesenteric venules 
(2.3±0.25 x 10-7 cm⋅s-1 (28)), our collecting lymphatic Pd must be compared to rat 
mesenteric venular Pd, for which no reported measures exist. The scarcity of mammalian 
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Pd data underscores the need for future experiments to elucidate Pd to albumin in rat 
mesenteric microvessels to form a complete description of the network permeability, 
inclusive of all vessel types.  
The Péclet number describes the ratio of convective to diffusive transport of 
solute. In these experiments albumin, a carrier of free fatty acids, hormones, and drugs, 
was used because it is the major determinant of oncotic pressure in intact, autoperfused 
tissues. At the mean hydrostatic pressure for collecting lymphatics (7 cmH2O, Table 1) 
the calculated Pé = 0.36, meaning that ~40% of albumin transport was mediated by 
convection through pathways/structures through which water and solute travel together 
and ~60% of albumin crosses by pressure-independent mechanisms. If the permeability 
properties of rat mesenteric venules and collecting lymphatics are similar, the venular Pé 
value would be ~1 at their greater hydrostatic pressure of 20 cmH2O. In contrast, Pé for 
isolated rat skeletal muscle venules at 20 cmH2O is 0.13 (107). It is notable that the 
difference between these two values likely reflects the fact that PsBSA of skeletal muscle 
venules is an order of magnitude greater than mesenteric venular PsRSA, indicative of the 
difference in metabolic demand of the two tissues (107) or the difference in permeability 
to BSA relative to RSA as a result of differing charges (14, 102).  
Others have reported Ps to BSA (14±7 x 10-7 cm⋅s-1, (98)) from a confluent tube of 
lymphatic endothelial cells (D = ~100µm). Though this PsBSA is from a vessel with a 
diameter similar to that of rat mesenteric collecting lymphatics, it likely represents 
microlymphatic vessel permeability due to the lack of basement membrane, smooth 
muscle, and pericytes. In support of this notion, from a single microlymphatic vessel 
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cannulated in vivo we measured a PsRSA of 12 x 10-7 cm⋅s-1 (D = 37.8 µm, PLumen = 3 
cmH2O). While cell culture is a valuable system for studying the molecular mechanisms 
regulating permeability, caution should be exercised when interpreting these Ps values.  
Influence of Pressure on Collecting Lymphatic Spontaneous Contractions 
Figure 3 demonstrates the effect of hydrostatic pressure, and hence flow, on the 
spontaneous contraction frequency of collecting lymphatics. Studies show (38) that with 
increased flow, there is a decrease in spontaneous contraction frequency mediated in part 
by nitric oxide. Others (142) have demonstrated that in the absence of flow, elevation in 
pressure alone is sufficient to diminish contraction amplitude. Fig. 3A shows that a 
collecting lymphatic vessel perfused at a relatively low pressure possesses spontaneous 
contractions compared to a vessel in Fig. 3B with a higher perfusion pressure lacking 
spontaneous contractions. Both forces are likely involved. After cannulation 
approximately half of the Ps recordings exhibited spontaneous contractions, while absent 
in the other half. Since solute flux is affected by pressure as a result of convective 
coupling, the PsRSA values between contracting and non-contracting vessels differed, 
although the direct effect of spontaneous contractions versus a contribution of flow 
cannot be extracted from these data. While some vessels lacked spontaneous 
contractions, this occurred invariably after cannulation and only at relatively high 
pressure and/or flow. 
Assumptions for Modeled Solute and Volume Flux Over Pressure 
With knowledge of Lp and Pd the graph of volume flux against pressure can be 
constructed once we know the reflection coefficient (σ) of the vessel and the oncotic 
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pressure difference (∆π = πL - πi). As a first approximation, given the similarity in solute 
permeability parameters Ps and Pd, we assumed that σ for albumin does not differ 
between the two vessel types. The value that has been measured for rat mesenteric 
venules is 0.94 (61). The other parameter that must be known is the oncotic pressure 
difference across the lymphatic vessel wall (πL - πi), for which the reported values vary 
considerably. Therefore, the albumin concentrations of lymph, peritoneal fluid, and 
plasma were measured directly (Table 2), facilitating the calculation of the oncotic 
pressure difference for albumin. Ideally, interstitial fluid should be sampled instead of 
peritoneal fluid, but the latter has been shown to be only modestly more concentrated 
than the former (10). For all graphs of flux, the interstitial pressure (Pi) is assumed to 
equal zero.  
Estimation of Collecting Lymphatic Vessel Hydraulic Conductivity (Lp) 
Although these studies were aimed at determining permeability to solute, the 
question remains: what is the magnitude of the ‘hydraulic permeability coefficient’, Lp, 
and does that differ from rat mesenteric venular Lp? To address this, we examined the 
limiting slope of Fig. 5, which defines Lp(1 - σ), and assumed that collecting lymphatic σ 
was identical to the rat mesenteric venular σ of 0.94 (61). The calculated Lp is 2.2 x 10-7 
cm⋅s-1⋅cmH2O-1, similar to basal values measured in rat mesenteric venules (2.4±0.2 x 10-
7 cm⋅s-1⋅cmH2O-1, (61); 2.6±0.3 x 10-7 cm⋅s-1⋅cmH2O-1, (63); 2.4 x 10-7 cm⋅s-1⋅cmH2O-1, 
(103)). To validate this estimation, experiments are needed to measure hydraulic 
conductivity for rat mesenteric collecting lymphatics, which will provide the remaining 
permeability values for both albumin (σ) and water (Lp).  
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Predicted Solute and Volume Flux from Measured Albumin Concentration Differences 
Table 2 (Fig. 6) provides evidence that lymph taken from a typical rat mesenteric 
collecting lymphatic can possess a greater concentration of albumin than that found in 
surrounding peritoneal fluid. Since interstitial fluid is slightly less concentrated than 
peritoneal fluid (10), we can confidently state that the albumin concentration in lymph is 
greater than the interstitial concentration, at least for vessels in rat mesentery. The total 
protein lymph-to-plasma ratio of 77% agrees well with previous studies reporting 70% in 
the rat tail (7). More interestingly, the albumin-to-total protein ratio for each 
compartment differed, suggesting non-uniform albumin handling within each 
compartment.   
Figure 7A shows that albumin flux (Js) is outwardly directed since ∆C is a 
positive value, where the positive direction is from the vessel to the interstitium. Finding 
in vivo evidence supporting solute extravasation is intriguing since collecting lymphatics 
are believed to only absorb protein and fluid (13, 16, 43). Fig. 7B indicates an outwardly 
directed volume flux in both the transient (solid line) and steady state (dashed curve) 
conditions. The steady state relationship shows that constitutive reabsorption of fluid by 
collecting lymphatics cannot occur, which confirms that proposed by Michel for 
microvessels (82). However, collecting lymphatics of this study were observed to 
contract spontaneously at frequencies of 10-15 min-1; consequently, a steady state 
pressure is never attained. Thus, description of physiological collecting lymphatic volume 
flux is better represented by the transient graph of volume flux on pressure (Fig. 7B). 
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While filtration of fluid occurs over most of the pressures observed in this study, at low 
pressures (< 1.5 cmH2O) reabsorption of fluid is possible.  
Physiological Significance of Collecting Lymphatic Permeability Properties 
The measured values of albumin flux led us to accept our hypothesis that rat 
mesenteric collecting lymphatics are no different than venules with respect to albumin 
permeability, which supports the proposal that the cardinal vein is the origin of lymphatic 
endothelium (114). Further, our data show that a positive concentration difference is 
possible (Table 2) such that solute moves from the vessel lumen towards the interstitium, 
a result that opposes the current expectations that lymphatic vessels should only absorb 
protein and fluid. While the concentration differences for lymphatic vessels of every 
organ may not be positive, these data demonstrate that the capacity for lymphatic solute 
exchange exists. A consequence of an outwardly directed and convectively coupled 
albumin flux is that during increased lymphatic hydrostatic pressure a greater amount of 
albumin is extravasated, increasing the interstitial albumin concentration and likelihood 
for edema formation. Therefore, additional studies are needed to elucidate the regulation 
of lymphatic solute permeability in the context of edema formation.  
If the ideal graphs of volume flux represent the behavior of most rat mesenteric 
collecting lymphatic vessels, they have important implications for edema and overall 
fluid balance. For instance, collecting lymphatic hydrostatic pressure is elevated during 
lymphedema and according to Fig. 7B enhances fluid filtration that, if sufficient, is 
expected to produce a low-protein edema. Further, a higher hydrostatic pressure inhibits 
spontaneous contractions so that volume flux follows the steady state curve (Fig. 7B) for 
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which fluid reabsorption is no longer possible. Although the volume flux predictions are 
approximations, and it is probable that not all collecting lymphatic vessels possess the 
same oncotic pressure difference, the albumin concentration data in Table 2 show that it 
is likely that macromolecules in lymph of prenodal collecting lymphatics are more 
concentrated than in the surrounding interstitial fluid. Together our solute flux data and 
volume flux estimates support the theory that prenodal collecting lymphatics concentrate 
their luminal protein (17, 56, 119) by preferentially losing water over solute (depicted in 
Fig. 8). Experiments to determine collecting lymphatic hydraulic conductivity are needed 
to fully delineate the conditions that produce edemas of lymphatic origin. 
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Supplemental Methods 
Surgical Preparation 
 
All experiments were performed in situ on juvenile male (35-55 days, 200-250g) 
Sprague Dawley rat mesenteric microvessels (Hilltop Lab Animals, PA, USA). Animals 
were housed 3 to a cage for a minimum one-week acclimation period prior to the 
experiment. For these initial studies, juvenile male animals were chosen for their lack of 
visceral fat, which facilitated location and subsequent cannulation of collecting 
lymphatics. One venule or collecting lymphatic was cannulated per animal. On the day of 
the experiment, the animal was weighed and anesthetized by intraperitoneal injection of 
Inactin (thiobutabarbital, Research Biochemicals Int., MA, USA, 128 mg/kg body 
weight). After the abdomen was shaved, the animal was placed atop a custom Plexiglas™ 
board in the supine position on a layer of Sylgard™ that contained coiled Tygon™ tubing 
attached to a circulating heater to maintain body temperature at 37 ± 0.5°C. A small loop 
of intestine was exposed carefully through a midline abdominal incision prior to placing 
the rat in the left lateral decubitis position and draping the mesentery over a Sylgard™ 
pillar (2 cm diam.). The mesentery was superfused continuously (2-3 mL/min) with 
mammalian Krebs at 37 ± 0.5°C and the intestine was covered with small strips of Krebs-
moistened gauze. After locating a vessel under the Zeiss dissection microscope, the 
animal and board were transferred to a Leitz Diavert inverted microscope and the 
suffused preparation was allowed to equilibrate for approximately 30 minutes prior to 
cannulation and data gathering.  
In Vivo Collecting Lymphatic Vessel Cannulation 
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The instruments for in situ collecting lymphatic vessel cannulation, consisting of 
one beveled cannulating micropipette and one restraining rod, were fabricated according 
to the methods previously detailed by this lab (80). As with blood microvessels, it was 
discovered that the tip size of the micropipette was a major factor that determined 
successful cannulation and microvessel perfusion. For collecting lymphatics the two 
major considerations were that: 1) upon contact with the micropipette, the collecting 
lymphatic vessel would immediately constrict, presumably as a result of injury if the tip 
is too large; and 2) if the micropipette tip was too small, cannulation was relatively easy, 
but complete filling of the vessel lumen thereafter, a requirement for measurement of 
solute flux, was impossible. Therefore, the optimal micropipette size seemed to be 
approximately one third the diameter of the lymphatic vessel to obtain both ease of 
cannulation and complete filling of the vessel lumen.  
The most successful micropipettes (success >90%) were made from single lumen 
capillary glass (WPI, FL, USA; cat# TW150-6) beveled at a 27.5° angle from the pipette 
axis (tip diameter, 25-30 µm) on a motorized grinding wheel (Narashige, Japan) using 0.3 
µm diamond grit paper (AH Thomas, NJ). After grinding the pipettes were washed, 
siliconized with SurfaSil™ (Pierce Biotechnology, IL, USA), and dried with acetone. The 
first half of the experiments were performed with theta pipettes (Sutter Instrument, CA, 
USA; cat# BT-150-10) because they allowed a washout and a test solution to be used 
without recannulation. However, the cross section of a theta pipette is elliptical, instead 
of circular, causing greater trauma to the lymphatic vessel and dramatically reducing the 
success rate. Once it was determined that the likelihood of obtaining data was higher 
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using the single-lumen micropipettes, and that the absolute measures of flux did not differ 
with pipette type, the use of theta pipettes was discontinued.  
To cannulate the vessel, a beveled pipette filled with the fluorescent perfusate 
solution was connected to a water manometer system, set to a low positive pressure (≤2 
cmH2O), and positioned (Prior micromanipulator with fine z-axis control, UK) near the 
cannulation site parallel to the vessel. A restraining rod, made from a pulled micropipette 
with the tip passed quickly through a flame and then also mounted on a Prior 
micromanipulator, was lowered onto the mesentery 20-50 µm away from the vessel and 
positioned at a ~90° angle to the vessel. The restraining rod was used to gently stretch the 
vessel axially and slightly radially. After the micropipette was lowered to barely make 
contact with the top surface of the vessel, it was advanced forward with the aid of a single 
dimension hydraulic drive (HAER, Brunswick, ME) along its axis in the direction of 
lymph flow while keeping the tip in the focal plane so that the vessel wall folded onto the 
micropipette. Care was taken to avoid touching the endothelium on the bottom surface of 
the vessel.  If at any time a lymphatic vessel constricted during this process all movement 
was halted until the lymphatic recovered. Finally, the micropipette was advanced forward 
along the vessel axis to penetrate the wall. Once in the vessel lumen, the pressure in the 
micropipette was raised just enough to prevent aspiration of lymph.  
Intravital Microscopy for In Vivo Measurement of Collecting Lymphatic Permeability 
To make measurements of solute flux using theta pipettes, a baseline fluorescence 
was established with the washout solution, followed by a switch to 5-30 minutes of dye 
perfusion, and then switched back to the washout solution to prepare the vessel for 
  56 
another measurement of flux. In the other half of the experiments the method we expect 
to use in future studies was employed. A siliconized, single lumen micropipette attached 
to the manometer system was used to perfuse the collecting lymphatic vessel with dye 
after measuring PLumen. To reestablish the baseline fluorescence, the vessel was quickly 
recannulated with a separate micropipette containing the washout solution.  
The perfused microvessels were visualized with brightfield under Köhler 
illumination on a Leitz Diavert inverted microscope with a 10x objective (numerical 
aperture 0.22, UM10, Leitz, NJ, USA). Following cannulation, the brightfield illuminator 
was turned off, and a shutter was opened to allow epifluorescent illumination through an 
I2/3 filter cube for Alexa-488 (band pass: 450-490nm, long pass: 515nm, Leitz, NJ, 
USA). The light path was split 50:50, and projected simultaneously onto a black and 
white, low light CCD camera (IC-200, PTI, NJ, USA) and an analog photometer (D-
104C, PTI, NJ, USA). Before reaching the photometer, the emitted fluorescence was 
reflected off a dichroic mirror (595nm, Chroma, VT, USA), and passed through an 
emission filter (band pass: 515-543nm, Chroma, VT, USA). The image of the low light 
camera was displayed on a 14” monitor (WV-BM 1400, Panasonic, NJ, USA) before 
being sent to a DVD recorder (DVO-1000 MD, Sony, NJ, USA).  
Direct measures of solute flux (Js, mmol/s) were made over an area of vessel 
defined by a rectangular adjustable diaphragm in the light path of the photometer (width 
≥4 vessel diameters, length = 8 vessel diam.), which served to limit interference from 
stray light. Fluorescence filled the vessel lumen resulting in an initial step increase in 
fluorescence intensity (Io), followed by a gradual but linear increase in intensity as the 
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fluorescent probe continuously flowing through the vessel segment began to accumulate 
in the interstitial space over time (dIf/dt). Apparent solute permeability (Ps, cm⋅s-1) was 
calculated from the equation relating solute flux (Js, mmol⋅s-1) to surface area (S, cm2) at 
a constant concentration difference (ΔC, mmol⋅mL-1)(50):  
Ps = Js/SΔC = (1/Io)(dIf/dt)(D/4)                                           (2.1). 
Vessels were assumed to be circular and to have a volume-to-surface area ratio of D/4.  
Preparation of Fluorescently Labeled Protein 
Proteins, BSA or RSA, for use in the perfusate or suffusate solutions were 
"washed" with saline prior to use. In this procedure dialysis is achieved by ultrafiltration 
(Amicon 30kDa molecular weight cutoff, Millipore, MA, USA). The dialyzed BSA and 
RSA were stored in 10 mL and 100 µl aliquots, respectively, at a concentration of 100 
mg/mL at -20°C until the day of the experiment.  
Briefly, the Alexa-488 and RSA (3:1 molar ratio) were reacted for 30 minutes at 
room temperature. Free fluorescent dye was removed first by centrifugation using 
Vivaspin™ 20 (30kDa nominal molecular weight limit, VivaScience, Hanover, 
Germany); remaining free dye was removed by buffer exchange column chromatography. 
Protein concentration of the conjugate was determined by Micro BCA Protein Assay 
(Thermo Fisher Scientific, IL, USA) and stored at a final concentration of 10 mg/mL at -
20°C. 
Determination of Albumin and Total Protein Concentration from Lymph Samples 
Total protein concentration of each plasma, lymph, or peritoneal fluid sample was 
determined by the Micro BCA Protein Assay utilizing BSA as a standard. Albumin 
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concentration of each sample was determined by the Albumin Blue 580 Fluorescence 
assay (62) using RSA as the standard. Volumes were adapted to a 96-well plate. The 
albumin or total protein concentration was then used to calculate the albumin or total 
protein oncotic pressures, respectively, for each sample using the Landis-Pappenheimer 
equations (67).  
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CHAPTER 3: COLLECTING LYMPHATIC VESSEL PERMEABILITY AND 
CONTRACTILE RESPONSES ELICITED BY ATRIAL AND BRAIN 
NATRIURETIC PEPTIDES 
 
Abstract 
Atrial and brain natriuretic peptides (ANP and BNP, respectively) are cardiac hormones 
released into the bloodstream in response to hypervolemia or fluid shifts to the central 
circulation. The actions of both peptides include natriuresis and diuresis, a decrease in 
systemic blood pressure, and inhibition of the renin-angiotensin-aldosterone system. 
Furthermore, ANP and BNP elicit modest, but significant increases in blood microvessel 
permeability, leading to protein and fluid extravasation into the interstitium (i.e. third 
spacing). Due to the importance of the lymphatic vasculature in maintaining fluid 
balance, we tested the hypothesis that perfusion with ANP or BNP increases lymphatic 
permeability (Ps) to rat serum albumin by 2-fold. Using a microfluorometric technique 
adapted to lymphatic vessels, we determined the rat mesenteric collecting lymphatic Ps 
responses to ANP and BNP were 2.0±0.4-fold (p=0.01, N=7) and 2.7±0.8-fold (p=0.07, 
N=7), respectively, consistent with the responses of other vessel types. In addition to 
measuring Ps responses, we were able to observe changes in spontaneous contraction 
amplitude and frequency from the albumin flux tracings. Notably, ANP abolished 
spontaneous contraction amplitude (p=0.005) and frequency (p=0.006), while BNP 
augmented both by ~2-fold (p<0.01 each). We conclude that ANP and BNP target 
collecting lymphatics by elevating their permeability to an extent similar to blood 
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microvessels and differentially altering their contractile function. In aggregate, our data 
support the theory that increases in collecting lymphatic permeability oppose the 
absorptive function of the lymphatic vasculature, trapping protein and fluid in the 
interstitial space as a compensatory response to volume expansion.  
 
Introduction 
Natriuretic peptides (NPs), a class of peptide hormones synthesized by the 
chambers of the heart, are released into the bloodstream upon cardiac stretch resulting 
from hypervolemia or fluid shifts favoring the central circulation (e.g. microgravity, 
swimming, cardiac failure) to reduce vascular fluid volume. As a result, NPs have been 
the focus of investigation for treatment of congestive heart failure (CHF) due to their 
numerous favorable physiological actions (77). Likewise, the lymphatic vasculature is a 
critical regulator of fluid distribution (19, 73, 110) and owing to this commonality the 
effects of NPs on lymphatic vessel function encourage study.  
In healthy humans there is a constitutive low-level secretion of atrial (ANP) and 
brain natriuretic peptides (BNP), synthesized by the atria and ventricles of the heart, 
respectively (23). Notably, the heart is the main source for these circulating peptides 
although other organs are capable of secreting NPs (e.g. brain, lung), albeit at lower 
levels (39). C-type natriuretic peptide (CNP) is the exception to the rule, being 
synthesized and released mainly from the vascular endothelium as an autocrine hormone. 
Natriuretic peptide signaling occurs upon binding to one of the three natriuretic peptide 
receptors (NPR-A, -B, and -C). NPR-A and -B are the particulate, membrane-bound 
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guanylyl cyclase receptors, while NPR-C lacks this activity. ANP and BNP bind to NPR-
A with similar binding affinities that are much greater than that of CNP (118). The NPR-
C receptor, lacking the catalytic cytoplasmic tail, is believed to be a ‘clearance’ receptor 
and binds ANP with an affinity greater than CNP, which is greater than that of BNP 
(118). 
Elevation of circulating ANP or BNP stimulates the well-established 
physiological responses of marked natriuresis and diuresis, a decrease in systemic blood 
pressure, inhibition of the renin-angiotensin-aldosterone system, and at high 
concentrations, vasodilatation (77, 101, 138). De Bold (34) observed an additional 
property of ANP infusion: a redistribution of vascular volume (increase in hematocrit) 
later shown to occur in the absence of the kidneys (3). It was then demonstrated that in 
selected tissues and portions of the vasculature, ANP elicited a rapid and sustained 
increase in microvascular permeability to both protein and water (29, 51, 80, 81). A 
response of this magnitude is sufficient to displace a significant portion of the circulating 
fluid and protein into the interstitium (125, 127), thus alleviating volume overload 
whether perceived (e.g. CHF) or real (e.g. microgravity). Another study investigating the 
permeability response of venular capillaries to BNP demonstrated a response mimicking 
that of ANP (79).  
In a recent study, we confirmed that in the condition of health, collecting 
lymphatic vessel permeability to albumin does not differ from that of venules (110). 
Since a defining feature of the lymphatic vasculature is to control fluid distribution 
between the vascular and interstitial spaces, we hypothesized that collecting lymphatic 
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permeability to albumin would be elevated 2-fold upon exposure to 100 nM of either 
ANP or BNP, a response similar to that of venular capillaries (79, 80). Our rationale for 
hypothesizing equal lymphatic and venular responses arose from a study reporting that 
lymphatic endothelium is derived from the cardinal vein during embryological 
development (114), which led us to reason that a consequence of their similar genetic 
profiles may be comparable function.  
Paired measures of albumin flux were made during perfusion of in situ rat 
mesenteric collecting lymphatics with control and natriuretic peptide solutions containing 
fluorescently labeled albumin, from which solute permeability was determined. We 
accepted our hypothesis that lymphatics would, like the venules, undergo a 2-fold 
increase in permeability to albumin (Ps) during ANP exposure and that lymphatic 
permeability responses to ANP and BNP would not differ. Additionally, we observed that 
the contractile features of collecting lymphatic vessels were altered differentially during 
ANP versus BNP treatment and tested whether nitric oxide played a role in the alteration 
of lymphatic contractile function in response to ANP. We conclude that the lymphatic 
vasculature represents an additional target of natriuretic peptide signaling and additional 
surface area from which protein and fluid may extravasate to relieve vascular volume 
expansion.  
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Methods 
Ethical Approval:  
Animal protocols were approved by the Institutional Animal Care and Use 
Committee (IACUC) at the University of Missouri-Columbia and conducted in 
accordance with the National Institutes of Health’s Guide for the Care and Use of 
Laboratory Animals. All animals were killed after the experiment by an overdose of 
anaesthetic followed by bilateral pneumothorax and aortic transection to conform to the 
protocol.  
 
General Surgical Preparation:  
All experiments were performed in situ on juvenile male (35-55 days, 200-250g) 
Sprague Dawley rats (Hilltop Lab Animals, PA, USA) housed 3 to a cage for a minimum 
one-week acclimation period prior to the experiment. Juvenile males were chosen for 
their relative lack of perivascular fat, which facilitated location and subsequent 
cannulation of mesenteric collecting lymphatics. One collecting lymphatic (60-170 µm 
diameter) was cannulated per animal.  
Following induction of anesthesia with Inactin (IP, thiobutabarbital, Research 
Biochemicals Int., MA, USA, 128 mg/kg body weight), the animal was placed on a 
custom, heated Plexiglas™ board that enabled transport of the animal from a dissection 
microscope to an intravital microscope. The mesentery was exteriorized and superfused 
continuously (2-3 mL/min) with mammalian Krebs at 37 ± 0.5°C while a vessel was 
located under the Zeiss dissection microscope. The animal and board were then 
  64 
transferred to a Leitz Diavert inverted microscope and the suffused preparation was 
allowed to equilibrate for approximately 30 minutes prior to vessel cannulation and data 
collection.  
 
Collecting Lymphatic Vessel Nomenclature and Identification: 
The nomenclature of lymphatic vessels described in this manuscript conforms to 
that previously described (110). Collecting lymphatic vessels were identified by the 
presence of valves, spontaneous contractions, and their transparent contents (143). 
Additionally, leukocytes were often visualized in collecting lymphatics. Vessels shrouded 
by adipose tissue were not studied because the fat cells hinder cannulation.  
 
Solutions:  
Mammalian Krebs. All superfusion and perfusion solutions were prepared fresh 
and used on the same day. Unless otherwise stated all materials were purchased from 
Sigma (MO, USA). The Krebs superfusion solution consisted of (in mmol): 141.4 NaCl, 
4.7 KCl, 2.0 CaCl2⋅2H2O, 1.2 MgSO4, 1.2 NaH2PO4⋅H2O, 5.0 d-glucose, 3.0 NaHCO3, 
and 1.5 NaHEPES. The pH of the solution was 7.4 ± 0.05 at 37°C.  
Krebs-BSA. Dialyzed bovine serum albumin (BSA, Sigma cat# A7906) was added 
to the Krebs superfusion solution to achieve a final concentration of 1 mg/mL on the day 
of the experiment. The osmolarity, measured by freezing point osmometry, was generally 
between 292-297 mOsm after the addition of BSA. 
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Labeled Protein. The macromolecular probe used in this study, rat serum albumin 
(RSA, Sigma cat# A6272), was bound to the Alexa-488 fluorophore (Invitrogen, CA, 
USA) by modifying the manufacturer’s protocol. Briefly, the Alexa-488 and RSA (3:1 
molar ratio) were reacted for 30 minutes at room temperature. Free fluorescent dye was 
removed in two steps: first by centrifugation using Vivaspin™ 20 (30kDa nominal 
molecular weight limit, VivaScience, Hanover, Germany); second, any remaining free 
dye was removed by buffer exchange column chromatography. Protein concentration of 
the conjugate was determined by Micro BCA Protein Assay (Thermo Fisher Scientific, 
IL, USA) and stored at a final concentration of 10 mg/mL at -20°C. This approach 
removes unconjugated dye while preserving the primary structure of albumin (14). 
The perfusate solution contained 10% (w/v) labeled RSA (1 mg) with 9 mg of 
unlabeled RSA and was brought to a volume of 1 mL with freshly made Krebs solution 
so that the final total protein concentration was 10 mg/mL. A washout solution was made, 
with unlabeled protein, at an identical total protein concentration. Both solutions of 10 
mg/mL RSA possessed an oncotic pressure of 4.1 cmH2O calculated from the Landis-
Pappenheimer equation (67).  
Dialysis Procedure for BSA and RSA. Proteins (BSA or RSA) for use in the 
perfusate or suffusate solutions were "washed" with saline to remove hydrophilic solutes 
carried on albumin prior to use. In this procedure dialysis is achieved by ultrafiltration 
(Amicon 30kDa molecular weight cutoff, Millipore, MA, USA). The dialyzed BSA and 
RSA were stored in 10 mL and 100 µl aliquots, respectively, at a concentration of 100 
mg/mL at -20°C until the day of the experiment. 
  66 
Perfusates Containing Natriuretic Peptide and/or L-NMMA. Rat atrial natriuretic 
peptide (ANP, Sigma cat# A8208) and brain natriuretic peptide (BNP, Sigma cat# 
B9901) were dissolved in saline to prepare 10 µM stock solutions. The 100x stock 
solutions were divided into 15 µL aliquots and stored at -20°C. On the day of the 
experiment, an ANP or BNP aliquot was thawed and 5 µL of stock solution were added 
to 500 µL (half) of the perfusion solution to a final concentration of 100 nM. The other 
half of the perfusion solution was used as the control. For natriuretic peptides the 
concentration of 100 nM was chosen to elicit a maximal Ps response (81). NG-
monomethyl-L-arginine (L-NMMA; Calbiochem, CA, USA; cat# 475886) was treated in 
a similar manner by dissolving it in saline to obtain a 1 mM stock solution. The 100x 
stock solution was aliquoted in 1 mL amounts and stored at -20°C. On the day of use, an 
aliquot was thawed and 10 µL of this stock replaced 10 µL of the Krebs superfusion 
solution that was used as a diluent for the 1 mL perfusion solution yielding a final 
concentration of 10 µM, a dose sufficient to eliminate nitric oxide production (38).  
 
Microvascular Solute Flux Measurements:  
The method we use for determining solute permeability (Ps) to proteins in 
lymphatic and blood microvessels and its limitations is described in several publications 
(50, 80, 104, 107, 110). Briefly, collecting lymphatics studied here were cannulated in 
situ with single lumen pipettes and perfused with unlabeled RSA (washout) followed by 
fluorescently labeled RSA (dye) in Krebs solution. Vessel diameter (D) was measured 
under brightfield via an ocular ruler following all measures of Ps. For all Ps and 
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contractile responses, recordings were taken from the same vessel segment throughout 
the experiment for accuracy.  
Direct measures of albumin flux (Js, mmol⋅s-1) were made over an area of vessel 
defined by a rectangular diaphragm (width = 4 vessel diameters, length = 8 vessel diam.) 
in front of a photometer (PTI, Canada). When dye-labeled albumin filled the vessel 
lumen there was an initial step increase in fluorescence intensity (Io), followed by a 
gradual, but linear, increase in intensity as fluorescent probe accumulated in the 
interstitial space over time (dIf/dt) in addition to the constant signal generated from the 
fluorophore flowing through the vessel lumen. Solute permeability (Ps, cm⋅s-1) was 
calculated from the equation relating solute flux (Js, mmol⋅s-1) to surface area (S, cm2) at 
a constant concentration difference (ΔC, mmol⋅mL-1) (50):  
Ps = Js/SΔC = (1/Io)(dIf/dt)(D/4)                                           (3.1). 
 
Contraction Amplitude and Frequency Assessment: 
 During the measurement of solute flux, we noticed that fluctuations in the 
fluorescence intensity tracing corresponded to collecting lymphatic vessel spontaneous 
contractions. To measure amplitude and frequency, the tracings were analyzed in the 
following manner: for measures of amplitude changes, the height of the fluorescent 
intensity oscillations were recorded as arbitrary units (blocks on the grid paper); the 
contraction frequency was obtained by counting the number of oscillations per unit time 
using the same chart recording paper. A similar method has been reported where total 
fluorescence intensity, which corresponds to volume, was used to control for vessel 
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cross-sectional area (129). One may object that changes in volume (πr2l) may not be the 
same magnitude as changes in diameter (r), but for these minute diameters volume varies 
linearly with diameter (R2 = 0.99).  
 
Experimental Protocols  
Collecting lymphatic vessels were entered into one of three protocols. In the first, 
designed to measure the permeability responses to ANP and BNP, a vessel was 
cannulated and perfused with the washout solution to measure baseline fluorescence, then 
recannulated and perfused with the dye solution so that both Io and dIf/dt were obtained. 
This provided the control Ps measurement. The Ps response was obtained by 
recannulating the vessel with the washout solution for a period of time sufficient to return 
tissue fluorescence to baseline, and then recannulating the vessel a final time with a 
pipette containing the dye and natriuretic peptide solution. In the second protocol, 
designed to allow observation of the contractile responses to ANP and BNP, a vessel was 
cannulated and perfused with the dye solution at a hydrostatic pressure just above the 
native vessel pressure (to elicit flow without inhibiting contractions (38, 110, 142)). To 
obtain the contractile responses to NPs, the vessel was recannulated and perfused at the 
same hydrostatic pressure with a pipette containing both the dye and natriuretic peptide. 
In the third protocol, vessels were treated similarly to the first protocol (in an attempt to 
measure Ps along with contractile responses), except that they were cannulated again with 
a solution containing both ANP and L-NMMA after a washout period.  
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Statistical Analyses: 
Prism™ (GraphPad Software, CA, USA) software was used for all statistics. The 
mean ± standard error of the mean (S.E.M.) was reported to facilitate comparison with 
published data.  Student’s paired t-tests were performed for the permeability and 
contractile function experiments where only two treatments were used. The Student’s 
unpaired t-test was utilized to compare the Ps responses to ANP and BNP. To determine 
whether fitted curves differed between treatment groups, the extra-sum-of-squares F test 
was performed. When more than two treatments were employed, differences were 
determined by one-way ANOVA in conjunction with Tukey’s post-hoc analysis for 
multiple pairwise comparisons.  
Power analysis was performed beforehand using the mean and standard deviation 
from our previous study (110) as a first approximation. To detect a 40% change in 
collecting lymphatic Ps between groups (2.0 x 10-7 cm⋅s-1) with 95% confidence 
(significance level p < 0.05), approximately 6 animals were needed per group (86).  
 
Results 
Collecting Lymphatic Vessel Permeability Responses to Two Natriuretic Peptides 
Figures 9A, 9B, and 9C each present data from 7 collecting lymphatic vessels. 
Solute permeability (Ps) was assessed during perfusion with a control (Krebs) solution 
followed by an identical solution containing 100 nM atrial (ANP; Fig. 9A,C) or brain 
natriuretic peptide (BNP; Fig. 9B,C). Both natriuretic peptide solutions induced increases 
in Ps to RSA (p = 0.01 for ANP and p = 0.07 for BNP) without eliciting appreciable 
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changes in vessel diameter. Because the distributions of Ps during peptide exposure 
appeared to differ slightly, the ratios were graphed in Figure 9C for further analysis. The 
fold changes in Ps elicited by ANP and BNP did not differ (p = 0.44) as the mean±S.E.M. 
Ps responses to ANP and to BNP were 2.0±0.4-fold and 2.7±0.8-fold increases, 
respectively. Further, when the one vessel that did not respond to BNP was excluded 
from the analysis, the permeability response reached statistical significance (p = 0.04). 
Sensitivity of Collecting Lymphatic Permeability Responses to Natriuretic Peptides 
Previous work from this laboratory with venular capillaries demonstrated that the 
response to ANP was more robust in vessels with a lower basal Ps (i.e. tighter barrier) 
(80). To determine whether collecting lymphatic vessels shared this feature, the fold 
increases in Ps to either ANP or BNP were graphed as a function of the control Ps in Fig. 
10. Not only did lymphatic Ps responses to ANP recapitulate this characteristic of venular 
capillaries, but Ps responses to BNP also followed the same general trend. While the 
means of the responses did not differ between the two groups (Fig. 9C), the curve fitted 
to the BNP response data (r2 = 0. 46, N = 6) was shifted to the right compared to the ANP 
response curve (r2 = 0. 91, N = 7). An extra-sum-of-squares F test was performed to 
determine whether one curve was sufficient to fit all the data, and concluded that two 
curves were needed (p < 0.05), indicating that the right shift was statistically significant. 
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Diffusion- and Convective-Mediated Albumin Flux are Similarly Affected by ANP 
Solute moves across vessel walls chiefly by two mechanisms: by diffusion and/or 
by solvent (or convective) drag when solute becomes entrained by water movement. 
Figure 11 illustrates the contribution of each of these mechanisms to solute flux. In Fig. 
11 the Ps responses to ANP (N = 6, excluding the one unresponsive vessel) were plotted 
as a function of the net pressure (difference between hydrostatic and oncotic pressures) at 
which they were assessed. The oncotic pressure of the perfusate, 3.85 cmH2O, was 
calculated according to the Landis-Pappenheimer equations (67) as described previously 
(110). The axis intercept of each flux curve at the translymphatic pressure of zero defines 
the diffusional permeability, Pd, and the limiting slope is equal to Lp(1 - σ), a measure of 
water permeability. While scatter in the data render the two curves as indistinguishable 
statistically, physiologically relevant information may still be obtained (Fig. 12), namely 
Pd and Lp(1 - σ). The estimated values of Pd and Lp(1 - σ) under control conditions were 
3 x 10-7 cm⋅s-1 and 0.3 x 10-7 cm⋅s-1⋅cmH2O-1, respectively (Fig. 12A and 12B). During 
perfusion with ANP, Pd and Lp(1 - σ) rose to 5 x 10-7 cm⋅s-1 and 0.5 x 10-7 cm⋅s-1⋅cmH2O-
1, respectively. Of significance, Pd and Lp(1 - σ) were almost doubled upon exposure to 
ANP with ~1.8 fold changes for each. The Péclet number (Pé), a unitless ratio describing 
the contributions of convective relative to diffusional solute flux, was calculated for the 
average collecting lymphatic hydrostatic pressure of 7 cmH2O (refer to (110)) to yield 
remarkably similar values for control and ANP-modified Péclet numbers (0.66 vs. 0.70, 
respectively; Fig. 12C).  
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Collecting Lymphatic Contractile Parameters are Altered Upon Natriuretic Peptide 
Exposure in a Nitric Oxide-Dependent Manner 
During measurement of albumin flux from collecting lymphatic vessels, we 
observed that the fluorescence intensity tracing recorded the amplitude and frequency of 
lymphatic spontaneous contractions, and could be used as a method to evaluate these 
parameters. The lymphatic contraction amplitude and frequency responses to either ANP 
(Fig. 13A and 13B) or BNP (Fig. 14C and 14D) were observed. Strikingly, in every 
vessel perfused with ANP spontaneous contractions were abolished completely 
(amplitude, p = 0.005; frequency p = 0.006). In marked contrast, perfusion with BNP 
resulted in stronger (p = 0.01) and more frequent (p = 0.01) contractions. The mean 
contraction amplitude and frequency responses to BNP were 2.2- and 2.1-fold increases, 
respectively.  
Review of the literature revealed that spontaneous contractions of collecting 
lymphatic vessels appear to be mediated by nitric oxide (NO) (38, 66) and there is 
accruing evidence that ANP on binding to the natriuretic peptide “clearance” receptor 
initiates the NO signaling cascade (5, 25, 47, 83, 137). To test the hypothesis that NO 
mediated the inhibition of spontaneous contractions during exposure to ANP, we 
performed an additional set of experiments (N = 3). In this case the vessels were perfused 
with a control solution, followed by the same solution containing 100 nM ANP, and 
ending with an identical solution containing both ANP and 10 µM L-NMMA. Figure 15 
summarizes the data from this group of experiments. Control amplitude and frequency 
differed from that during ANP infusion (p < 0.05), which eliminated spontaneous 
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contractions. L-NMMA treatment in the presence of ANP restored contraction amplitude 
and frequency, and thus differed significantly from the ANP group (p < 0.05) but not 
from the control (p > 0.05). 
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Discussion 
The lymphatic vasculature is well documented to absorb protein-containing fluid 
from the interstitium (8, 113). More recent reports, however, are showing that lymphatic 
vessels are capable of both absorption and extravasation of protein and fluid (19, 110) 
likely as a mechanism to control the fluid distribution between the tissue and vascular 
spaces. Therefore, the present study aimed to clarify whether, and to what extent, NPs, 
which are released into the circulation on volume expansion, modulate collecting 
lymphatic vessel permeability. We accepted our hypothesis that in vivo collecting 
lymphatics respond to ANP and BNP through an increase in permeability to albumin (Ps) 
and that the response does not differ between peptides. Further, when the coupling of 
albumin flux to water flux was examined with respect to ANP treatment, pathways 
carrying albumin and water were affected similarly. Overall, our data supported that 
lymphatic vessels are capable of regulating their Ps in response to changes in circulating 
natriuretic peptides and the theory that lymphatic extravasation of protein and water is a 
compensatory response to volume overload.  
Collecting Lymphatic Vessel Permeability to Albumin: Responses to ANP and BNP 
The lymphatic Ps responses to ANP and BNP were a 2-fold elevation above 
control and compare well with the 2-3-fold response reported previously for venular 
capillaries (80). That collecting lymphatic vessels appear to mirror the venules with 
respect to regulation of microvascular permeability supports further the rationale that 
these two vessel types likely possess similar function as a result of their common 
embryological origin (114). In addition, the responses to ANP and BNP do not differ 
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statistically, although there is a tendency for a stronger mean Ps response to BNP (2.0±0.4 
versus 2.7±0.8 fold). When sensitivity of the lymphatic Ps response is viewed graphically 
(i.e. when the response is plotted against control Ps in Fig. 10), it becomes evident that on 
exposure to ANP, a lymphatic vessel with a lower basal Ps will respond more strongly 
than a vessel with a higher basal Ps, confirming the relationship of the venular hydraulic 
conductivity response to ANP (80). Interestingly, when the Ps response to BNP is plotted 
on the same graph the fitted curve is shifted to the right of the ANP data. From this 
relationship we conclude that although the mean lymphatic Ps responses to ANP and 
BNP do not differ, a single vessel with a low basal Ps (< 4.0 x 10-7 cm⋅s-1) will likely 
produce a stronger response to BNP than ANP (compare Fig. 9B with Fig. 9A).  
If changes in lymphatic diameter occurred with either peptide, they were beyond 
the resolution of the ocular ruler, especially during lymphatic contractions. According to 
Brookes and Kaufman (18), we should have expected a <5% increase in diameter, which 
would equate to <5 µm, much less than one eyepiece unit of 12 µm. A previous study 
(57) also failed to observe any changes in diameter upon perfusion of rat skeletal muscle 
arterioles with 1 nM ANP (p = 0.3), under conditions where changes on the order of 5 µm 
could be resolved, suggesting that the lack of vasodilatation is not limited to collecting 
lymphatics.  
The present study could be criticized for comparing Ps responses from rat 
mesentery to those obtained from frog mesentery (80, 81). Yet data from preceding 
studies demonstrated that 1 nM ANP elicited increases in Ps of rat skeletal muscle 
arterioles on the order of 1.6±0.2-fold (N=12, p < 0.01) (57) and of porcine coronary 
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arterioles, 2.0±0.6-fold (N=7, p < 0.05) (55). Therefore, the microvascular permeability 
responses to ANP appear to be of similar magnitude among these three species.  
The data thus far illustrate that lymphatic permeability to the protein, albumin, is 
elevated significantly in response to atrial and brain natriuretic peptides. However, during 
volume expansion a shift of fluid – in addition to protein – from the vascular space to the 
tissues would be necessary to relieve volume overload and stress on the heart. To address 
how water transport might be affected, we graphed the control and ANP treatment Ps 
measures as a function of net driving pressure (hydrostatic minus oncotic pressures) 
across the lymphatic vessel wall (Fig. 11). While the two curves do not differ statistically, 
likely reflecting the distribution in Ps data that have been described as non-normal and 
left skewed (110), the two curves can still provide physiologically relevant data, namely, 
estimates of the diffusive permeability (Pd) and Lp(1 - σ). Apparent from Fig. 12 are that 
both Lp(1 - σ) (a measure of volume flux through the pathways conducting both fluid and 
protein) and Pd (a measure of diffusive protein permeability) are nearly doubled upon 
treatment of collecting lymphatics with ANP. Because Pé is the ratio that describes 
water-driven (Lp(1 - σ)) to diffusion-mediated (Pd) solute flux, it does not change with 
ANP perfusion consistent with a study of venules (80). The Pé value (Fig. 12C) also 
suggests that if lymphatic Lp (i.e. hydraulic conductivity) undergoes an increase similar in 
magnitude to Pd during perfusion with ANP, then the reflection coefficient, σ, would not 
change. The latter scenario likely describes the effect of ANP on lymphatic Lp as the 
basal lymphatic Ps and its response mirrored that of the venules, for which σ has been 
demonstrated not to change during ANP infusion (80, 81) or to provide another example, 
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during hyperglycemia (95). Additionally, changes in pore size (σ) result in large, 
exponential increases in Lp (to the fourth power if the transendothelial pathways are 
cylindrical or the second power if they are described by slits (27)). Instead for changes to 
occur in Lp and Pd comparable to those measured here, either the number of ‘pores’ 
doubled or the thickness of the transendothelial channels was halved. While it is possible 
that a fraction of the permeability to albumin reflects a vesicular transport mechanism, 
the changes in Pd and Lp(1 - σ) are not consistent with changes occurring solely in this 
pressure-independent component (i.e. increases in vesicular turnover would not change 
Lp(1 - σ)). These data point to the need for a follow-up study of lymphatic hydraulic 
conductivity to measure not only whole vessel lymphatic Lp and its response to NPs, but 
also to determine whether the lymphatic σ is altered by NPs.  
Collecting Lymphatic Vessel Contractile Function is Altered Differentially by ANP and 
BNP 
While we were recording albumin flux of collecting lymphatics, we observed that 
the contraction amplitude and frequency were affected by ANP and BNP. Strikingly, 
every lymphatic vessel exposed to ANP lost spontaneous contractions altogether (Fig. 
13A and 13B), a finding that is supported by the literature (90). In contrast to the ANP 
response, BNP increased both contraction amplitude and frequency by approximately 
twofold (Fig. 14A and 14B). Upon reviewing the literature, we formulated and tested the 
hypothesis that ANP stimulates nitric oxide (NO) production, a known inhibitor of 
lymphatic spontaneous contractions (132, 139). To our surprise L-NMMA, an inhibitor of 
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NO production, perfused in the same solution with ANP (Fig. 15) restored lymphatic 
contraction amplitude and frequency to control levels for every vessel.  
Mounting evidence supports the theory that ANP upon binding to the NPR-C 
‘clearance’ receptor can stimulate NO production (5, 25, 47, 83, 137). The current 
hypothesis (depicted in Fig. 16) is that NPR-C is a Gi-protein coupled receptor that not 
only inhibits adenylyl cyclase, but also activates endothelial nitric oxide synthase to 
produce NO, which binds to the soluble guanylyl cyclase receptor to produce cGMP (5). 
Our lymphatic contractile data fit well with this theory because the inhibition of NO 
synthesis reversed completely the effects of ANP, suggesting, consistent with others 
(132), that cGMP inhibits collecting lymphatic spontaneous contractions. Importantly, 
one must not neglect that we chose to use 100 nM ANP and BNP to elicit maximal 
responses and that others reported a dose-dependent effect of ANP on lymphatic 
contractile function (90), unlike our experience with solute permeability or hydraulic 
conductivity (81). Therefore, with lower doses of ANP and BNP we would expect 
attenuation, not inhibition, of spontaneous contractions. 
In a single collecting lymphatic vessel measures of Ps to albumin were made 
under control, ANP, and ANP+L-NMMA treatments. ANP treatment doubled Ps as 
before, but adding L-NMMA to ANP failed to abolish the Ps response. Instead, L-
NMMA caused a further doubling in Ps beyond ANP treatment alone. To account for this 
unexpected result, we surmise that treatment with L-NMMA eliminated NO production 
and therefore halted the conversion of GTP to cGMP by the soluble guanylyl cyclase 
receptor, leaving additional substrate in the form of GTP for the NPR-A receptor (Fig. 
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16, dashed lines). Notably, NPR-A would convert this excess GTP to cGMP, which 
serves to increase endothelial permeability and at the same time the NPR-C receptor 
would inhibit the formation of cAMP that serves to otherwise attenuate endothelial 
permeability (135).  
That the permeability responses to ANP and BNP did not differ, while the 
contractile responses were polarized, illustrates clearly that contraction, per se, is not a 
mechanism regulating the barrier properties of the collecting lymphatics. Net volume 
flux, though, might be expected to differ depending on how attenuation or potentiation of 
spontaneous contractions affect hydrostatic pressure. With respect to BNP, the increased 
contractile activity is expected to cause greater excursions in pressure, thereby increasing 
net volume flux (Figure 7) and reducing the efficiency of lymph flow (38, 130). Because 
ANP would attenuate the contractile activity, lymph flow is still expected to be lessened, 
but a more constant pressure might produce a smaller volume flux than that of BNP (Fig. 
7).  
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Physiological Significance of the Lymphatic Responses to Natriuretic Peptides 
The data obtained from this study revealed that rat mesenteric collecting 
lymphatic vessels respond to ANP and BNP by doubling their permeability to albumin. 
Further, collecting lymphatic spontaneous contractions were abolished completely by 
ANP, but became stronger and faster with perfusion of BNP. Importantly, one must 
realize that increases in solute permeability, and likely hydraulic conductivity, serve to 
augment the rate of protein and fluid extravasation from the microvasculature into the 
interstitium as demonstrated by others (19, 110, 125, 127). An extravasation of fluid and 
protein of this magnitude reduces the vascular volume by preventing the capillary filtrate 
from being absorbed and returned to the bloodstream by the lymphatic vasculature. We 
propose that the modest dilation of lymphatic vessels caused by ANP (18) would act to 
slow lymph flow and increase lymph volume to enable a greater loss of fluid and protein 
into the tissue spaces, suggesting that modulation of permeability is a primary function of 
NPs in the lymphatic vasculature. Moreover, we expect that attenuation of lymphatic 
contractions by ANP, and potentiation by BNP, will further reduce the efficiency of 
lymph flow (38, 130). Finally, it remains to be determined which of these peptides 
dictates contractile activity under the in vivo condition where the collecting lymphatics 
are presented with a mixture of ANP and BNP of varying ratios, such as is encountered 
during congestive heart failure.  
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CHAPTER 4: GENERAL DISCUSSION 
 
Armed with a more complete understanding of lymphatic vessel permeability 
developed over the last two chapters, we now return to the questions posed originally in 
the Specific Aims section of this dissertation: 1) are lymphatic vessels absorptive, leaky, 
or are they impermeable; 2) would increases in collecting lymphatic permeability be 
expected to resolve or create edema; and, 3) do collecting lymphatics really concentrate 
solute along their length? More importantly, we can now conclude that Hypotheses 1 and 
2 were accepted; i.e. that collecting lymphatic permeability to albumin does not differ 
from that of the venules, and that vasoactive peptides would elevate this permeability 
from control. The next few sections will examine these raised questions and the 
implications of the answers obtained in the context of the data presented here. 
 
Lymphatic Barrier Properties 
Before discussing the permeability properties of collecting lymphatic vessels, a 
brief outline of what is known about their barrier will be presented, as this influences the 
ability of solute and water to traverse the vessel wall. The lymphatic barrier (going from 
the lumen to the tissue) is comprised of an endothelial layer, followed by a basement 
membrane and pericytes, and ends with lymphatic muscle cells at the vessel-tissue 
interface. Whether lymphatic muscle, or even vascular smooth muscle on venules, poses 
a significant barrier to solute or volume flux is unknown.  
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Interestingly, initial lymphatic vessels lack pericytes, whereas collecting 
lymphatic vessels do not (96). This pattern opposes that seen in the blood 
microvasculature where smaller capillaries are vested with pericytes, but the larger vessel 
pericytes are relatively lacking. Initial lymphatics (a.k.a. lymphatic capillaries) have a 
much larger diameter than traditional blood-filled capillaries, but so do blood endothelial 
cell tubes cultured in the absence of pericytes, reflecting the role for pericytes in 
stabilizing endothelial tubes by inducing basement membrane accretion (117). Still 
remaining to be tested is whether pericytes are able to modulate endothelial permeability, 
be they of a blood or lymphatic origin.  
Collecting lymphatic vessels possess intraluminal valves, resembling those 
identified in the larger veins. When the vessel wall is stained for smooth muscle actin and 
imaged, a lack of lymphatic muscle around the valves can be visualized. In addition, we 
have observed in some vessels focal leaks of fluorescently labeled albumin from around 
the valve regions (unpublished observations). A role for lymphatic muscle in comprising 
part of the barrier to solute and water should be thoroughly investigated.  
For blood microvessels, a glycocalyx has been described as an endothelial 
secretion of glycoproteins that contain sialic and hyaluronic acid (54). Germane to the 
interpretation of this work, the glycocalyx hinders solute movement due to its web like 
structure and its highly negative charge. Since albumin is also negatively charged its 
transport is restricted by this structure. If a glycocalyx were present on the lymphatic 
endothelium, one would expect that it is similar in composition to that of the blood 
microvessels, since the permeability to albumin of these two vessel types does not differ.  
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However, a protein that bears resemblance to those of the blood microvessel 
glycocalyx has been identified, and may comprise part of the putative lymphatic 
glycocalyx. Podoplanin, also known as glycoprotein-38, is a negatively charged protein 
(due to O-glycosylation and that it contains sialic acid, constituents of the microvessel 
glycocalyx (108)) present on the luminal side of lymphatic endothelium, and is absent 
completely from blood microvessel endothelium (112). When this protein is lost from 
podocytes in the kidney, proteinuria ensues suggesting a role for this protein in 
maintaining a patent barrier against solute (65). If the glycocalyx of lymphatic vessels 
differs from blood vessels in the face of similar permeability properties, then other 
proteins may be involved. Another related protein, podocalyxin, is not expressed on 
lymphatic endothelium but is abundant on blood microvessel endothelium (123). Further 
research is necessary to tease out the presence, components, and significance of a 
lymphatic glycocalyx. 
 
Albumin and Volume Flux Within the Lymphatic Vasculature 
In Chapter 2 the assessment of collecting lymphatic vessel (CLV) permeability to 
albumin leads to the conclusion that, indeed, CLV are permeable to protein. When the 
question arises as to whether this solute flux is significant physiologically, we can 
conclude that it is because we show that the permeability between CLV and venules does 
not differ. Further, albumin transport was found to be dependent upon hydrostatic 
pressure, which would only occur if some of the albumin was crossing the endothelium 
through pathways conducting albumin and water. Therefore, these vessels likely conduct 
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water across the endothelial barrier in a manner analogous to the venules. Finally, if one 
models solute and fluid flux across the barrier, assuming that the reflection coefficients 
do not differ between the two vessel types, then the hydraulic conductivities between 
CLV and venules do not differ. These findings are striking given the differences between 
CLV and venules – their in vivo hydrostatic pressures, surface areas, and flow velocities 
all differ, not to mention that CLV generate spontaneous contractions at a regular 
frequency giving rise to a pulsatile pressure and flow, while venules possess a steady 
state pressure and flow. This last point argues for a mechanism by which CLV regulate 
their permeability properties at a basal set point near that of the venules. Future 
experiments will be needed to determine whether the permeability responses (e.g. to 
inflammatory mediators, exercise, signaling molecules, etc.) differ between these two 
vessel types.  
To answer whether CLV are absorptive or leaky (i.e. whether solute is transported 
from or into the vessel lumen) simultaneous measures of lymph, interstitial fluid, and 
plasma protein concentrations indicated that for CLV, at least in rat mesentery, a protein 
gradient existed favoring the net expulsion of protein and fluid. The result is further 
supported by experiments performed in the rat splenic microvasculature, where FITC-
labeled BSA leaked from the lymphatic vessels into the interstitium upon endotoxemia or 
infusion of ANP (18, 19). Macromolecule extravasation cannot occur if the concentration 
gradient across the lymphatic vessel wall is not such that the protein concentration inside 
the vessel is higher than in the interstitium. It is also highly unlikely that the ANP 
infusion or endotoxemia caused the concentration gradient to reverse spontaneously 
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within a short time period. Therefore, one can deduce that the rat spleen is another organ 
containing lymphatic vessels from which macromolecules diffuse into the interstitium 
under basal conditions. 
Concerning the movement of water across the lymphatic wall, estimates were 
made of lymphatic hydraulic conductivity (Lp) from the measures of albumin flux. In 
addition, collecting lymphatic hydrostatic pressures were measured prior to assessing 
lymphatic solute permeability (Ps). From these two pieces of information, a convincing 
argument was made for the filtration of water from collecting lymphatics into the 
interstitium as a consequence of the oscillating pressures in the lymphatic vasculature. 
The spontaneous contractions of collecting lymphatics generate a pulsatile pressure and 
flow, which places the volume flux on the transient state line (Eqn. 2.5), rather than the 
steady state relationship (Eqn. 2.6a; Figure 7B). Significantly, vessels undergoing 
transient changes in pressure, thus volume flux, are capable of transient fluid absorption. 
In contrast, vessels at a steady state pressure cannot reabsorb fluid (Fig. 6B) and 
constantly filter a finite amount of water (e.g. venules). For collecting lymphatics the 
estimated hydrostatic pressure below which fluid reabsorption occurs is 1.5 cmH2O. For 
individual vessels the threshold pressure below which fluid reabsorption occurs will vary, 
but to ascertain the real Lp and σ of albumin, which determine this threshold value, 
experiments must be designed carefully to measure these parameters in contracting 
lymphatic vessels.  
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Implications of Collecting Lymphatic Permeability Properties 
The data discussed thus far have profound consequences for overall fluid balance. 
The permeability properties of CLV are regulated such that a finite, significant 
extravasation of protein and water occurs. Any process, inflammatory or not, that 
increases the permeability of CLV to water and protein will promote edema via two 
mechanisms: 1) an increase in the rate of water and protein leak into the interstitium 
promotes edema directly; and 2) if the water loss from CLV is substantial, then the 
overall lymph flow will be compromised to cause a backup of the capillary filtrate into 
the interstitium, facilitating edema indirectly. Lymph flow can be expected to affect the 
efficiency of this process because a bolus of lymph flowing quickly through the CLV has 
less time to exchange its contents with the tissue compared to a bolus of lymph moving 
slower. Therefore, CLV permeability to water and solute must be considered an edema 
safety factor because its maintenance promotes fluid balance through direct and indirect 
means. 
That CLV are capable of continuous fluid reabsorption, while blood vessels (of 
any type) are not, carries its own significant implications. One is that CLV may be able to 
absorb fluid from the interstitium to alleviate the accumulation of interstitial fluid. If this 
is a normal process, then when the interstitial volume expands and increases interstitial 
pressure (and decreases interstitial oncotic pressure), the Starling forces would be shifted 
to favor absorption of excess fluid via this pathway. Secondly, if spontaneous 
contractions were to cease, then fluid transport would be shifted to the steady state 
relationship (Figure 7B) where fluid reabsorption would not be possible.  
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Another implication from this work is that the composition of lymph cannot be 
assumed to be identical to interstitial fluid. Several groups have proposed that CLV are 
able to concentrate their luminal contents (17, 56, 119), which would cause great error if 
one measured the oncotic pressure of lymph to assess that of interstitial fluid or if the 
lymph volume/protein concentration was used to assess capillary permeability. The 
potential of CLV to concentrate lymph is discussed below, as an extravasation of water 
from lymph is a mechanism that explains this effect. That macromolecules are retained in 
the CLV lumen relative to water argues that the lymphatic vasculature may be designed 
primarily for macromolecule and solute return to the blood, with the secondary 
consequence of returning some fluid.  
 
Is the Lymphatic Circulation Absorptive or Leaky? 
Taken together, the albumin flux data and volume flux models support our 
proposed theory of macromolecule handling by the lymphatic vasculature: that while the 
initial lymphatics absorb interstitial fluid, the concentration and pressure gradients of the 
microlymphatic and collecting lymphatic vessels (downstream) favor extravasation of a 
portion of this protein and water into the interstitium (Figs. 5 & 7). Furthermore, at a 
hydrostatic pressure of 5 cmH2O (close to the average CLV pressure), the Ps to albumin 
was less than 3 x 10-7 cm⋅s-1 whereas volume flux per unit surface area (Jv/S) at the same 
pressure was greater than 7 x 10-7 cm⋅s-1 (Fig. 7). The effect is augmented at a higher, yet 
still physiological, pressure of 10 cmH2O with a Ps to albumin of  ~3 x 10-7 cm⋅s-1 versus 
a Jv/S of ~18 x 10-7 cm⋅s-1. Thus, water traverses the CLV barrier approximately 3-6 
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times faster than does albumin, depending on the pressure of the vessel. When these units 
of permeability (cm⋅s-1) are used to determine absolute amounts (i.e. flux; Js (mol⋅s-1) or 
Jv (L⋅s-1)) transported in one second per unit area (Fig. 17), a CLV segment loses only 
femtomoles of albumin compared to picoliters of water (10-15 mol versus 10-12 liters) – a 
thousand-fold difference! A result of this astonishing property is that over the length of 
the CLV, more water than solute travels into the interstitium thereby concentrating the 
luminal protein. These data explain the physiology underlying recurring claims that CLV 
are capable of concentrating their contents (17, 56, 119). For this reason one cannot 
assume that lymph is representative of interstitial fluid with regard to oncotic pressure, 
overall volume, or protein concentrations.  
Calculating the ratio of albumin flux to water flux (Js/Jv, mol/L) yields an 
approximate value of the vessel filtrate molarity. The CLV filtrate is 1.7 mM, while that 
of venules is twice as concentrated at 3.4 mM (at each vessel’s average hydrostatic 
pressure). So while the diffusional permeabilities of the two vessels to albumin do not 
differ, nor the hydraulic conductivities nor even the fluid fluxes, the luminal 
concentration of albumin in CLV is about half that of the venules (26.2 versus 13.2 
mg/mL RSA, Table 2) leading to a diminished filtrate concentration of the CLV relative 
to the venules. While more information is required regarding the protein concentration 
difference for microlymphatic vessels, which possess a 10-fold greater permeability to 
albumin than that of CLV, it would be interesting to determine the molarity of their 
filtrate as these vessels appear to possess a much greater cumulative area than the CLV.  
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A global conclusion, then, is that the lymphatic circulation is both an absorptive 
sump and a leaky pump. While the majority of functional research has focused on the 
lymphatic muscle pump, the regulation of lymphatic vessel permeability is an equally 
important, novel mechanism for the maintenance of fluid homeostasis. Factors regulating 
CLV permeability, as well as the consequences of an elevated permeability, are discussed 
next. 
 
Modification of Lymphatic Solute Permeability 
 To address the question of whether the lymphatic vasculature is able to modulate 
its permeability to solute, or whether it is simply a fixed value, the albumin permeability 
of CLV was determined in the absence and presence of two natriuretic peptides (Chapter 
3). Collecting lymphatics exhibited a rapid and sustained twofold elevation in 
permeability upon exposure to either 100 nM ANP or BNP, leading to the conclusion that 
CLV permeability is regulated actively in a manner similar to the rest of the blood 
microvasculature. In detail, this study demonstrated that natriuretic peptides, likely 
through the actions of cGMP, modulate CLV permeability and, through a nitric oxide-
dependent mechanism, they can either attenuate or potentiate lymphatic spontaneous 
contractions. The same signaling scheme has been elucidated in the context of 
mammalian venular permeability, in that cGMP elevates permeability and, conversely, 
cAMP leads to enhanced barrier function (135). In one study using lymphatic endothelial 
cells grown in a collagen tube, cAMP was found to enhance lymphatic barrier integrity 
through an increased expression of VE-cadherin (98). Together these data suggest that 
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natriuretic peptide signaling is conserved between lymphatic and blood microvessels. 
However, it remains to be determined if the same phosphodiesterase isoforms are present 
in the same amounts in lymphatic and blood endothelia and, if different, could lead to the 
interesting situation where lymphatic and microvessel permeability are differentially 
regulated.  
Paradoxically, ANP and BNP through binding the NPR-C receptor exert opposite 
effects on lymphatic muscle spontaneous contraction amplitude and frequency (Chapter 
3). A possible hypothesis that resolves this dilemma is that NPR-C signaling is 
constitutive and therefore regulates lymphatic muscle contractile activity not only during 
diseases where natriuretic peptides are released but also during conditions of health. 
Having a greater concentration of circulating BNP than ANP, then, would lead to the 
observed effects only if BNP inhibited the nitric oxide cascade after binding to NPR-C. 
The ratio of BNP to ANP would either increase or decrease lymphatic contractile activity, 
and would agree with BNP as a predictor of patient mortality in CHF. To test this 
hypothesis, experiments from Chapter 3 could be repeated with control, BNP, and 
BNP+sodium nitroprusside treatments (in the same vessel) to determine whether nitric 
oxide replacement mitigates or eliminates the potentiation of lymphatic contractions by 
BNP. 
Before continuing it is worth mentioning that all the data discussed thus far have 
demonstrated that collecting lymphatic permeability and its responses to natriuretic 
peptides mirror that of the venules. Because the embryologic origin of the lymphatic 
endothelium is the cardinal vein (114), and expression of Prox-1 alone is sufficient to 
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coerce a blood endothelial cell to become a lymphatic endothelial cell (60), we reasoned 
that lymphatic vessels share many genes, therefore function, with the blood 
microvasculature. However, it must be recognized that many genes differ between these 
two cell types and that Prox-1 is a transcription factor that likely controls the expression 
of numerous downstream proteins. One set of proteins that would be interesting to 
discover under the control of Prox-1 would be junctional adhesion proteins. Whether or 
not Prox-1 controls the lymphatic barrier is currently unknown.  
 The novel data presented in this dissertation are anticipated to influence several 
pathological states, especially pathologies associated with edema. The next few sections 
examine the possible interplay between lymphatic permeability and disease.  
 
Lymphatic Permeability in Pathology 
Edema, or the unchecked accumulation of protein and fluid in the tissue spaces, is 
a hallmark of inflammation that, by itself, is a component of several illnesses, some of 
which include allergic reactions, asthma, cancer, diabetes, ischemia/reperfusion injury, 
malnutrition, and obesity. Indeed, one of the earliest events in inflammation is a 
compromised endothelial barrier leading to an increase in protein and fluid extravasation 
that serves several functions (111). To date, this has only been studied with respect to 
microvascular permeability, since lymphatic vessels have been assumed to be 
impermeable or solely absorptive. Mentioned earlier, a possible consequence of elevated 
microvessel permeability in the absence of a corresponding increase in lymphatic 
permeability is that the capillary filtrate could be reabsorbed by the lymphatic 
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vasculature. To maintain an edematous state, microvessels and lymphatic vessels are 
expected to undergo permeability increases together, again supporting parallel signaling 
pathways between the two vessel types.  
 An intriguing hypothesis is that changes in microvessel and lymphatic 
permeability can become uncoupled, leading to differential regulation of their barriers. 
The literature has already hinted at this phenomenon, as a sufficient increase in lymphatic 
permeability unaccompanied by a corresponding change in microvessel permeability 
would be expected to give rise to lymphedema, any edema occurring solely from 
lymphatic dysfunction. Much attention has been placed on the importance of defective 
lymphatic pumping, not only because it is an obvious defining feature, but also because 
pumping is needed to transport lymph against a hydrostatic pressure gradient. However, 
some peculiar cases of lymphedema cannot be explained by reduced lymphatic pumping 
even after enhanced capillary filtration is taken into account. One example is breast 
cancer-related lymphedema, which is associated with lymph node removal and/or axillary 
radiation and obesity (87). Several hypotheses for the cause of this ailment have been 
tested, but do not wholly account for the fluid retention, delayed onset, or that a low-
protein edema is formed instead of the expected high-protein edema (11). A mechanism 
that has not been tested is whether surgery and/or radiation cause damage to the 
lymphatic circulation precipitating an increase in lymphatic permeability. A ‘lymphatic 
permeability edema’ would be expected to produce a low-protein edema, since water is 
lost across the lymphatic vessel wall more readily than solute.  
  102 
 Another important example comes from experimental models characterized by 
‘leaky’ lymphatic vessels but intact blood microvessel barriers. Specifically, mice 
heterozygous for the Prox-1 gene possess malformed, ‘leaky’ lymphatic vessels and 
develop adult-onset obesity (46). Therefore, it would be interesting to determine whether 
increases in lymphatic permeability lead to obesity, or whether the obesity in this mouse 
model is caused by signaling defects downstream of Prox-1, or both. The former case is 
an apt culprit, as collecting lymphatics in the mesentery drain the intestinal lacteals and 
are the only route for the absorption of dietary fats; an enhanced leakage of these fats into 
the tissue spaces may stimulate adipogenesis and obesity. Such a mechanism is not 
limited to the intestinal vasculature because lymphatic vessels throughout the body 
contain fatty acids, lipids, and cholesterol (74). Finally, this animal model implies that 
junctional protein expression may be under the control of Prox-1, a hypothesis that 
remains to be tested. 
 Recently, lymphatic vessel growth was assessed in a rat model of salt-sensitive 
hypertension where a compensatory lymphangiogenic response to high salt treatment 
occurred (73). Upon macrophage depletion the lymphangiogenic response was inhibited 
and blood pressure increased. While the results were interpreted as subsequent to 
macrophage expression of a tonicity responsive protein that controlled vascular 
endothelial growth factor-C signaling, it remains unknown whether the lymphatic 
endothelium itself could serve as a primary sensor of interstitial tonicity by expressing 
this protein (tonicity-responsive enhancer binding protein). Alternatively, another sensor 
(i.e. the heart) could target the lymphatic circulation. In many animal models of 
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hypertension, atrial natriuretic peptide plasma concentrations are elevated (105) and 
knockout of the NPR-A receptor results in hypertension and a volume expansion of 30%  
(59, 97). ANP and BNP, therefore, are expected to play a profound role in the 
maintenance of vascular volume not only during hypertension, but also during basal 
conditions. Combined with the data from this dissertation providing evidence for 
natriuretic peptide signaling in the lymphatic vasculature, it seems reasonable to propose 
that the lymphatic vasculature acts as a regulator of vascular volume by modulating its 
permeability. As a result systemic blood pressure might be affected indirectly. 
 Natriuretic peptides were originally thought to play a large role in congestive 
heart failure (CHF). However, natriuretic peptide receptor desensitization is believed to 
occur over time through receptor phosphorylation (97), limiting their usefulness as a 
treatment. In acute CHF, before receptor desensitization has a chance to occur, these 
peptides would be a major way to reduce volume load by elevating both lymphatic and 
microvessel permeability (short-term reduction), while at the same time eliciting diuresis 
to reduce vascular volume in the long-term. A novel mechanism was discovered during 
this dissertation work, that natriuretic peptides can additionally target the contractile 
activity of collecting lymphatics to reduce lymph flow, enabling a longer time for lymph-
tissue fluid and solute exchange (Chapter 3).  
 Although it is not a pathological state, per se, the arrangement of a venule 
draining a tissue bed adjacent to an arteriole feeding the same bed, named an 
‘arteriovenous pair’, has been proposed to allay pathogenesis. The significance of this 
countercurrent, parallel vessel arrangement is that inflammatory mediators drained by the 
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venules are able to diffuse to the arterioles, or cause a secondary diffusible signal to be 
released from the venule, with the end effect of modulating arteriolar tone, thus blood 
flow, capillary pressure, and capillary filtration (45). One important component of the 
vasculature, collecting lymphatic vessels, has been overlooked in this context because the 
permeability of these vessels had not been determined until now. A result of this thesis 
work is that collecting lymphatics are permeable and are capable of signaling nearby 
feeding arterioles. Here a new term should be presented to describe this ‘new’ threefold 
arrangement – ‘arteriovenolymphatic (AVL) triads’ – whose physiological relevance 
remains to be elucidated.  
 In conclusion, the regulation of lymphatic permeability is likely an unidentified 
feature of several disease conditions, in particular those that possess edema and/or 
inflammation components. Some implications of increasing lymphatic vessel 
permeability are that: 1) solute and protein will be lost to the tissue spaces to facilitate 
edema formation, 2) as a result lymph flow will be diminished to a proportional degree, 
and 3) inflammatory signals may diffuse from lymphatic vessels more readily to signal 
nearby tissues or vessels. Whether elevation of lymphatic permeability precedes 
leukocyte adhesion or rolling in collecting lymphatics must be examined. Finally, the 
permeability and contractile activity of the lymphatic vasculature may be an additional 
target for the regulation of vascular volume by natriuretic peptides and a causative factor 
in adult-onset obesity. 
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CHAPTER 5: CONCLUSION 
 
 The work presented within this dissertation was a direct test of 2 hypotheses: 1) 
that collecting lymphatic vessels are permeable to albumin to an extent that mimics that 
of the venules, and 2) that natriuretic peptides elicit twofold increases in collecting 
lymphatic permeability to albumin. Both hypotheses were accepted, suggesting that 
collecting lymphatic vessel permeability is regulated during conditions of health and 
illness. In addition, collecting lymphatic permeability resembles the permeability of 
venular microvessels not only under basal conditions, but also in its response to 
natriuretic peptide signaling. Functional distinctions between the two vessel types 
(including hydrostatic pressure, surface area, and lymphatic spontaneous contractions) 
are compensated for because their net fluid and protein transport are similar.  
In addition, several unexpected discoveries were made during the course of this 
project. One is that collecting lymphatics, at least in the rat mesentery, possess a greater 
concentration of total protein and albumin than is present in the interstitium leading to 
protein and fluid extravasation into the tissue spaces. A second was that collecting 
lymphatic fluid flux models predict, as a consequence of lymphatic phasic contractions, 
that both filtration and reabsorption of fluid by the lymphatic vasculature are possible. 
Lastly, ANP and BNP were found to exert opposing effects on the spontaneous 
contraction amplitude and frequency of lymphatic muscle, somehow by binding the same 
receptor. Overall, this dissertation establishes the lymphatic vasculature as both an 
absorptive sump and a leaky pump with profound implications in many diseases, as 
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changes in permeability properties are involved in the precipitation of edema and 
inflammation. In particular, lymphatic permeability dysregulation was proposed to be the 
missing cause of adult-onset obesity and discussed in the context of several pathologies.  
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APPENDIX 1: LIST OF ABBREVIATIONS 
 
AC, adenylyl cyclase 
ANP, atrial natriuretic peptide 
BNP, brain natriuretic peptide 
BSA, bovine serum albumin 
∆C, transmural concentration difference (mM) 
CHF, congestive heart failure 
CLV, collecting lymphatic vessel(s) 
CNP, C-type natriuretic peptide 
D, vessel diameter (cm) 
dIf/dt, rate of interstitial fluorescence accumulation 
FITC, fluorescein isothiocyanate dye 
If, fluorescence intensity 
Io, initial fluorescence intensity 
Js, solute flux (mmol⋅s-1) 
Jv, volume, or fluid, flux (mL⋅s-1 or cm3⋅s-1) 
Jv/S, volume flux per unit surface area (cm⋅s-1) 
L-NAME, L-NG-nitroarginine methyl ester 
L-NMMA, NG-monomethyl-L-arginine  
Lp, hydraulic conductivity (cm⋅s-1⋅cmH2O-1) 
NO, nitric oxide 
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NPs, natriuretic peptides 
NPR, natriuretic peptide receptor (-A, -B, or -C) 
∆P, transmural hydrostatic pressure difference (cmH2O) 
Pc, microvessel hydrostatic pressure (cmH2O) 
Pd, diffusive permeability to solute (cm⋅s-1) 
pGC, particulate guanylate cyclase receptor 
Pi, interstitial hydrostatic pressure (cmH2O) 
Plumen, native vessel pressure (cmH2O), measured prior to solute flux in Chapter 2 
Ps or PsRSA, apparent solute permeability to rat serum albumin (cm⋅s-1) 
Pé, Péclet number (no units) 
RSA, rat serum albumin 
S, surface area (cm2) 
sGC, soluble guanylate cyclase receptor 
STD, spontaneous transient depolarizations 
∆π, transmural oncotic pressure difference (cmH2O) 
πc or πL, microvessel or lymphatic vessel oncotic pressure (cmH2O) 
πi, interstitial oncotic pressure (cmH2O) 
σ, reflection coefficient (no units) 
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APPENDIX 2: RAW DATA TABLES 
 
Table 1. Basal permeability (Ps) values for rat serum albumin.  
Date Vessel Type 
Diameter 
(µm) 
PLumen 
(cmH2O) 
PsRSA 
(x10-7 
cm/s) 
 
02/01/08 CL1 113 1 3.6  
06/03/08 CL2 76 10 4.0  
08/06/08 CL3 101 ~0 8.8  
08/11/08 CL4 88 2.5 16.7  
08/12/08 CL5 113 ~0 1.5  
08/27/08 CL6 101 5 4.8  
09/01/08 CL7 139 10 2.7  
09/05/08 CL8 139 16 1.0  
09/09/08 CL9 101 6 1.5  
09/24/08 CL10 139 11 2.7  
09/25/08 CL11 126 9 7.0  
10/20/08 CL12 139 12 2.7  
12/05/08 CL13 88 5 3.2  
12/17/08 CL14 88 9 6.4  
01/21/09 CL15 101 2 15.2  
01/23/09 CL16 88 ~0 4.0  
2/05/09 CL17 50 5 3.3  
02/06/09 CL18 126 10 9.9  
03/02/09 CL19 113 10 0.2  
03/05/09 CL20 63 5 3.1  
03/10/09 CL21 88.2 8.5 4.3  
03/11/09 CL22 88.2 8.5 3.2  
08/26/08 V1 63 20 6.1  
09/03/08 V2 38 23 6.2  
09/26/08 V3 50 17 3.3  
04/17/09 V4 25 17 3.9  
09/23/09 V5 38 21 4.1  
09/23/09 V6 38 17 9.1  
09/23/09 V7 38 20 3.4  
09/23/09 V8 25 21 0.5  
Mean ± S.E.M. CL 103 ± 5* 7 ± 1* 5.0 ± 0.9  
 V 39 ± 4 20 ± 1 4.6 ± 0.9  
Median ± MAD CL   3.5 ± 1  
 V   4.0 ± 1  
Ps values are x 10-7 cm⋅s-1; CL, collecting lymphatic; V, venule; PLumen, native vessel 
pressure (measured during relaxation phase for lymphatics); MAD, median absolute 
deviation; *, p<0.01 versus venules.  
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Table 2. Measured Total Protein and Albumin Concentration of Lymph, Peritoneal Fluid, 
and Plasma.  
 Plasma Peritoneal Fluid Lymph  
Total Protein (mg/mL) 41.6 ± 2.4 31.3 ± 0.9 32.4 ± 1.1  
Albumin (mg/mL) 26.2 ± 0.8 9.5 ± 1.5# 13.2 ± 1.5#  
Albumin/Total Protein Ratio (%) 63.4 ± 3.7 30.3 ± 4.5# 40.9 ± 5.1#  
Total Protein Oncotic Pressure* (cmH2O) 23.9 ± 1.7 7.2 ± 1.4† 9.4 ± 1.0†  
Albumin Oncotic Pressure* (cmH2O) 11.9 ± 0.4 3.9 ± 0.6
# 5.5 ± 0.7#  
*Oncotic pressure is calculated from the Landis-Pappenheimer equation for total protein 
or albumin, respectively. †, # Paired t-tests between peritoneal fluid and lymph; † p < 0.05, 
# p < 0.1. Values are reported as means ± SE from 4 animals. 
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Table 3. Permeability (Ps) to rat serum albumin during control and natriuretic peptide 
solution perfusion.  
Date Diameter (µm) 
PsRSA 
(x10-7 cm/s) 
PsANP 
(x10-7 cm/s) 
PsBNP 
(x10-7 cm/s) 
Response 
(fold) 
Perfusion 
P 
(cmH2O) 
 
02/06/09 126 9.9 18.9  1.9 25  
03/10/09 88 1.1 4.6  4.2 23  
03/10/09 88 7.5 6.4  0.86 29  
03/11/09 88 2.6 8.0  2.5 19  
11/03/09 164 8.5 13.3  1.6 25  
11/04/09 101 7.7 10.6  1.4 15  
03/10/10 113 8.3 12.0  1.5 15  
12/03/09 88 7.2  3.1 0.43 15  
01/19/10 126 2.0  2.9 1.5 15  
01/29/10 113 4.9  8.2 1.7 15  
02/09/10 113 9.5  13.1 1.4 15  
02/11/10 82 6.3  17.8 2.8 25  
02/17/10 101 5.5  29.3 5.3 15  
02/18/10 88 4.5  27.2 6.0 15  
Mean ± S.E.M. 106 ± 6 6.1 ± 0.7 10.5 ± 2 14.5 ± 4 2.4 ± 0.4 19 ± 1  
Ps values are x 10-7 cm⋅s-1; PsRSA, control permeability; PsANP, permeability to RSA during 
ANP perfusion; PsBNP, permeability to RSA during BNP perfusion.  
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